RGUHS General Medicine question bank

1. QMD –GM
(Question bank for MD General Medicine RGUHS ,2006-2018*)
13 years , 711 questions
By
Dr SANDEEP M R
MD GENERAL MEDICINE
MYSORE MEDICAL COLLEGE
RESIDENT CRITICAL CARE
BAPTIST HOSPIAL BANGALORE
*Except nov 2009 , paper 2& 4 nov 2014 – unavailable
NOT FOR SALE
1

2. QUESTION PAPER ANALYSIS
COMPLETE QUESTION REPEAT : 40 - 50%
TOPIC REPEAT : 75-85%
CLINICAL TOPICS : 10 -15%
INVESTIGATIONS AND UPDATES: 5 – 10%
MBBS BASICS : 5-10%
UNEXPECTED BOUNCERS : 5- 10%Hence my suggestion is to
read solve questions from question bank and read update which is easier
Method 1: Reading only Harrison – 70-80% ,level of difficulty is very high and
difficulty in revising for exams .advantage is esay to prepare for entrance
Method 2 : reading answers for the questions majority from Harrison(can do
notes if time permits ) ,some from API ,robbins ,clinical manuals and oxford
book of laboratory investigations . level of difficulty – medium . advantage is
easy to prepare for md exam after exam read remaining topics for entrance
*The above analysis is predictive the author is not responsible for any
further consequences and adverse effects
There will be no strict divisions of questions based on question paper
number .30% topics overlapping .the below division of questions based on
question paper number is arbitrary
2

3. PAPER ONE
SECTION 1 : CRITICAL CARE
Chapter 1 : FLUID AND ELECTROLYTES
1 Discuss the various causes of hypokalemia and its management ,chart to
approach . Repeat april 2008 RS,may 2018
2007 april
2 what are the causes of hyponatremia ? depict in a flowchart how to
approach hyponatremia .how will you manage a case of hyponatremia ?
(20)
2008 oct RS
3 What are the causes of hyperkalemia? depict in a flowchart how to
approach hyperkalemia .how will you manage a case of hyperkalemia ?
(20)
2010 may RS
4 Discuss calcium hemostasis in body and describe disorders arising from
its disturbance (20)
2011 may
5 etiology ,Clinical features and management of hypercalcemia repeat nov
2016 (20)
2012 may RS
6 Hypocalcemia 2012 nov rs
7 Write the calcium metabolism and how do you approach a case of
hypercalcemia (20)
2013 may
CHAPTER 2 NUTRITION
8 Vitamin A 2010 may
9 Vitamin A 2012 nov
10 What are the causes of vitamin D deficiency and discuss recent
concepts of vitamin D in human diseases?
2013 nov
11 Vitamin D and type 2 diabetes mellitus 2016 jun
12 Clinical features and management of osteomalacia 2013 may
13 Define malnutrition .Discuss nutritional deficiency diseases 2014 may
14 Describe the biochemical assessment of vitamin status in the
human body
2015 may
15 Trace elements 2010 may
16 Dietary fiber 2007 april
17 Antioxidants, physiological role and treatment complications .
Repeat -may 2010
2009 may RS
18 Discuss nutritional management in critical care 2008 oct
19 Discuss details of nutritional support in critically ill subjects (20) 2006 april
20 Total parenteral nutriton repeat nov 2013,nov 2014 2012 may RS
3

4. CHAPTER 3 :ACID BASE IMBALANCE
21 What are the major buffering systems in the body and how do they
function to maintain normal pH
200
7
sept
22 Discuss common metabolic decompensations and their management
in acute medical care unit
200
6
april
23 Discuss the acid base balance and its significance(20) 201
3
may
24 Anion gap 200
7
april
25 Lactic acidosis repeat may 2011 201
0
oct
26 respiratory alkalosis 201
5
oct
CHAPTER 4 :SHOCK,MODS,CARDIAC ARREST,BLS AND ALS
27 Pathophysiology of shock 2018 may
28 Define sepsis syndromes. discuss etiopathogenesis , diagnosis
and management of septicemia
2013 nov
29 Toxic shock syndrome 2012 nov
30 What is SIRS ? what are the noninfectious causes of SIRS ?
discuss the pathophysiology of sepsis and septic shock ?
2010 may
RS
31 Define shock and classify it and describe the management of
septic shock
2007 april
32 Describe "systemic inflamatory response "syndrome .what is
its pathogenesis and its management . Repeat nov 2017
2006 sept
33 "Activated protein C "its role in sepsis 2008 april
RS
34 Procalcitonin 2012 nov rs
35 Cardiopulmonary resuscitation 2008 oct RS
36 Clinical approach and management of cardiac arrest 2010 oct
37 Discuss the etiologies, pathophysiology and management of
cardiogenic shock (20) repeat may 2014
2012 nov
38 Discuss the diagnosis and management of fat embolism 2010 may
39 heridetary angioneurotic edema 2017 nov
40 Anaphylactic shock etiopathogenesis ,clinical features and
management repeat may 2017
2008 april
RS
CHAPTER 5 : RESPIRATORY FAILURE AND VENTILATOR SUPPORT
41 Define and classify respiratory failure .discuss their clinical
features and management (20)
2007 april
42 Classify respiratory failure 2012 nov
43 Etiopathogenesis and management of acute respiratory distress 2011 may
4

5. syndrome repeat nov 2012 RS
44 Write pathogenesis ,clinical features and management of adult
respiratory distress syndrome (20) repeat oct 2015
2010 may
45 Sever acute respiratory distress syndrome 2017 may
46 Non invasive ventilation repeat nov 2014,july 2016 2007 sept
SECTION 2: TOXICOLOGY
47 Describe the clinical diagnosis and management of intermediate
syndrome due to organophosphorus compound poisoning
2006 april
48 Management of organophosphorous poisoning 2007 sept
49 How will you manage a case of unknown poisoning ?write a note
on clinical features and management of organophosphorous
poisoning (20)
2008 oct
RS
50 Aluminium phosphide poisoning 2011 may
51 Paracetamol poisoning clinical features and management
pathogenesis repeat jun 2016,nov 2017
2011 may
RS
52 Gastric decontamination procedures in the management of acute
poisoning
2011 nov
RS
53 Tricyclic antidepressant overdose 2012 nov
54 Arsenic poisoning 2013 nov
55 Benzodiapene poisoning 2015 oct
56 Role of pralidoxime in organophosphorous poisoning 2016 jun
57 Methyl alcohol poisoning 2017 nov
58 Effects of ethanol on organ systems 2011 nov
59 Barbiturate poisoning 2008 april
60 Describe the metabolism of alcohol after ingestion .what is the
effect of alcohol on intermediary metabolism
2007 sept
61 Discuss the clinical features and management of snake
evenomation repeat jun 2017
2007 april
62 Describe clinical features and treatment of scorpion sting 2015 oct
CHAPTER 6 : TOXICOLOGY AND BITES
SECTION 3 : IMMUNOLOGY (except connective tissue disease )
CHAPTER 7 : IMMUNOLOGY
5

6. 63 Mechanisms of autoimmunity 2010 may
64 HLA system 2011 may
65 Discuss the role of complement in immunity repeat may 2013 2007 sept
66 Immune modulations 2006 sept
67 Name the autoantibodies and their association 2006 sept
68 Graft versus host disease repeat may 2013 2007 sept
69 Vaccination in transplant recepeints 2007 april
70 Adult immunization 2012 nov rs
71 briefly discuss autoimmunity and autoimmune polyglandular
syndrome
2015 may
SECTION 4: GENETICS
CHAPTER 8: GENETICS
72 Marfan's syndrome 2008 april
73 Genetics and pathogenesis of cystic fibrosis 2016 jun
74 Y -linked receptor 2007 april
75 Trinucleotide repeat sequences 2008 april
RS
76 polygenic inheritance 2010 may RS
77 Polymerase chain reaction 2013 nov
78 Describe recent developments in diagnostic tests using
molecular techniques (20)
2007 sept
79 Genetic counseling 2011 nov RS
80 Mitochondrial medicine 2016 jun
81 Kearns sayre syndrome 2013 may
82 Discuss the recent advances in gene therapy(20) repeat may
2001,april 2015
2008 oct
83 Flurosence in situ Hybridisation 2018 may
84 Human cloning 2007 april
SECTION 5 : MEDICINE IN SPECIAL POPULATION AND
ENVIRONMENTAL MEDICINE
CHAPTR 9 : GERIATRICS
85 Common geriatrics problem and their management 2008 oct RS
86 Describe the principles of geriatric medicine with appropriate
examples
2010 may
RS
87 Discuss aetiology, evaluation and management of falls in elderly
(20) repeat may 2011,nov 2017
2011 nov
88 Ethical issues in the aged with respect to self determination and
decision making in therapeutic options
2011 nov
RS
89 Drug usage in the elderly 2012 nov
6

7. 90 Describe the mechanisms of common drug-drug interaction
,giving examples of each. add a not on prescribing in elderly (20)
2015 may
91 Causes and management of urinary incontinence in geriatric age
group repeat nov 2017
2016 jun
92 Anticipatory care in old age and is rationale 2017 may
CHAPTER 10 :PREGNANCY AND ADOLESCENT MEDICINE
93 Hypertension in pregnancy -etiopathogeneis ,clinical features and
management repeat may 2011 RS,nov 2013,may 2018
200
8
april
RS
94 Management of heart disease in pregnancy 200
8
oct
RS
95 Effect of pregnancy on valvular heart disease 201
6
jun
96 Gestational diabetes repeat oct 2015 201
0
may
RS
97 Pathophysiology of gestaional diabetes mellitus 201
0
oct
98 Discuss jaundice in pregnancy (20) repeat nov 2017 201
1
may
99 Discuss physiology of thyroid hormones during pregnancy and how
do you manage a case of hyperthyroidism during pregnancy and
lactation ?(20)
201
4
nov
CHAPTER 11 :ENVIRONMENTAL MEDICINE
100 Discuss endemic flurosis 2007 april
101 Discuss thermoregulation .mention the causes ,clinical features
amd management of hypothermia
2010 may
102 Heat stroke repeat jun 2017 2011 may
103 Chronic mountain sickness 2011 may
104 High alitude pulmonary edema 2018 may
105 Malignant hyperthermia 2013 nov
106 outline the chronology of events rquired for induction of
fever ,mention causes for hyperthermia and
etiopathogenesis,clinicalfeatures ,diagnosis and management of
heat stroke (20)
2016 jun
107 Acute mountain sickness 2012 nov
108 Radiation sickness 2011 nov RS
108 Clinical features and treatment of endemic flurosis 2012 may RS
110 Discuss health hazards of prolonged alcohol consumption. 2012 nov rs
111 bioterrorism repeat may 2015,jun 2016 2013 may
112 Microbial terrorism 2014 may
SECTION 6 :RADIOLOGY,ANATOMY AND PHYSIOLOGY
CHAPTER 12
113 Positron emmision tomography repeat oct 2015 2014 nov
7

8. 114 MR spectroscopy 2017 nov
*ANATOMY AND PHYSIOLOGY QUESTIONS ARE MENTIONED UNDER
RESPECTIVE SYSTEMS
SECTION 7 :GENERAL TOPICS
CHAPTER 13: PATHOLGY ,MICROBIOLOGY,FORENSIC MDICINE ,GNERAL
MEDICINE ,ANESTHESIA
PATHOLOGY
115 Discuss the biochemistry,physiology ,pharmacology and clinical
significance of Nitric oxide (20)
2007 april
116 Nitric oxide physiological role and therapeutic implications 2008 oct RS
117 apoptosis repeat may 2013 2010 may
118 Theories of ageing 2008 april
RS
119 Hs CRP (highly sensitiive C reactive protein 2011 may
120 Coagulation cascade 2012 may RS
121 Discuss the biology of ageing .discuss briefly theories about
ageing and genetics of longetivity?how will you assess cognition
in elderly ?(20)
2014 nov
122 Describe the types of amyloid and clinical diseases caused by it 2015 may
OTHERS
123 pharmacogenomics 201
3
may
124 Discuss euthanasia, terminal illness management in relvance to
indian context
201
3
nov
125 hyperbaric oxyzen therapy 200
6
sept
126 Evidence based medicne 201
0
may
8

9. PAPER 2
SECTION 8 : INFECTIOUS DISEASES
CHAPTER 14:BACTERIOLOGY
GRAM POSITIVE
127 write the antibiotics used in MRSA infection 200
6
april
128 Discuss the pharmacology of vancomycin 200
8
oct
129 beta lactamase inhibitors 201
0
may
130 New delhi metallo-1 201
1
may
GRAM NEGATIVE
131 Classify quinolones and mention their uses ,mechanism
,contraindication and side effects repeat may 2011
200
6
april
132 Antibiotic management of multidrug resistant typhoid fever 200
6
sept
133 Discuss the diagnosis and managment of complicated typhoid fever 200
6
sept
134 Describe the microbiology of vibrio cholerae and describe the lab
diagnosis and its management .repeat may 2018
200
7
april
135 Leigonaires disease 200
7
sept
136 Clinical features and the treatment of septicemic plague 201
1
nov
MYCOBACTERIA
137 Define andTreatment of latent tuberculosis repeat nov 2014 201
0
may
RS
138 Outline criteria for diagnoses of pulmonary diseases due to non
tuberculous mycobacteria.describe the typical features of primary
and mention secondary pulmonary diseases due to mycobacerium
avium complex and mention the drug regimens for prevention and
treatment of pulmonary and disseminated diseases(20) repeat nov
2016
201
0
oct
139 Immunology of leprosy 201
6
jun
140 Lepra reaction repeat april 2008 200 sept
9

10. 7
141 Polyneuritic leprosy 200
6
april
142 Describe the diagnosis and management of intestinal tuberculosis 200
7
april
* PULMONARY TUBERCULOSIS MENTIONED UNDER RESPIRATORY
SYSTEM
OTHERS
143 Discuss the etiopathogenesis,clinical features,diagnosis and
management of leptospirosis (20) repeat oct 2008 RS ,oct
08,may 2009 RS,may 2018
2006 april
144 Lyme disease 2011 nov RS
145 poncets disease 2012 may RS
147 Scrub typhus 2013 may
147 Discuss the approach to patient with fever ,rash,bleeding
tndency and altered sensorium of recent onset
2017 may
148 Coombs test 2014 nov
149 Serologic tests for syphilis 2012 nov
150 Secondary syphilis 2016 nov
151 Adult vaccination 2017 nov
298 : Diagnosis and management of nocardiosis
640 Tigecycline
CHAPTER 15 : VIROLOGY
HIV
152 Hematological manifestations in HIV 200
6
sept
153 Discuss the indications for staring antiretroviral treatment
.classification of antiretroviral drugs and its side effects profile
NACO recommendations (20) repeat may 2014
200
8
oct
RS
154 Discuss HIV vaccine 200
8
oct
155 A 30 years old HIV infected patient presents with fever ,hypoxia and
cough of 10 days duration .discuss the differential diagnosis
,evaluation and management of this patient (20)
200
9
may
RS
156 CMV retinitis 200
9
may
RS
157 Describe the gastrointestinal manifestations of HIV/AiDS. discuss
post exposure prophylaxis
201
0
may
RS
158 Discuss HIV post exposure prophylaxis ( may 2014) 201
0
may
159 ElISA versus NAT(nucleic acid testing ) of transfusion transmissable
diseases
201
1
may
160 W H O clinical staging of HIV disease 201
1
nov
RS
10

11. 161 Morphology ,replication cycle of HIV and targets of antiretroviral
therapy
201
2
may
RS
162 Immune reconstitution inflammatory syndrome (IRIS) repeat may
2015,oct 2015
201
2
nov
163 Discuss the evaluation, and management of meningitis in a patient
with retro viral infection(20)
201
2
nov
rs
164 Mucocutaneous manifestations of HIV 201
3
nov
165 Discuss the mechanisms of temperature regulation and pathogenesis
of fever . Define pyrexia of unknown origin. How will you approach
a case of PUO in a HIV positive man ?(20)
201
4
nov
166 Outline the mechanism of CD4 t cell dysfunction and depletion in
HIV infection .give the accoun of relationship between CD4 t cells
and oppurtunistic infection (20) repeat july 2016
201
6
jun
167 Discuss respiratory manifestations of HIV 201
6
nov
168 Occupational risks for health workers 201
6
nov
169 HIV/TB co infection 201
8
may
OTHERS
170 Dengue fever 2008 april
171 Dengue shock syndrome 2017 nov
172 Discuss aetiology, clinical features, complication and
management of swine flu (20)
2011 nov RS
173 H1N1 prophylaxis 2012 may RS
174 Drug therapy of chronic hepatitis B 2012 may RS
175 Discuss etiology,clinical features ,complications and
management of chikungunya
2014 may
CHAPTER 16 :PARASITOLOGY
MALARIA
176 Management of cerebral malaria 2006 sept
177 Complications of falciparum malaria and management . Repeat
may 2018
2008 april
178 Complicated malaria -clinical features and management repeat
nov 2016
2008 april
RS
179 Malaria prophylaxis 2008 oct RS
180 Discuss tropical splenomegaly repeat may 2010 Rs 2008 oct
181 Discuss manaagement of chloroquine resistant falciparum
malaria
2010 may
182 Cerebral malaria 2011 nov RS
183 Malaria vaccines 2012 nov
184 Discuss the etiopathogenesis ,clinical features,complications
and management of falciparum malaria (20)
2013 may
Others
11

12. 185 Eye lesion in toxoplasmosis 200
6
apri
l
16
186 Cerebral toxoplasmosis may 2012 RS,oct 2015 200
9
may
RS
16
187 Giardiasis 200
7
sept 16
188 Extra intestinal amoebiasis 201
1
nov 16
189 Kala azar /leishmaniasis epidemology ,pathognesis,clinical
features and management repeat may 2017,may 2018
201
4
may 16
190 Strongyloidosis 201
3
may 16
191 Hook worm infestations 201
7
nov 16
192 pneumocystis carni pneumonia- etiopathogensis ,clinical
features,complications ,management(20) repeat july 2016
200
8
apri
l
17
CHAPTER 17:MYCOLOGY
*Questions mentioned under respiratory system and candidiasis under
HIV
*Clinical syndromes of infectious diseases are mentioned under respected
systems
SECTION 9 : CARDIOVASCULAR SYSTEM
CHAPTER 18: CVS ANATOMY AND PHYSIOLOGY
193 Discuss hyperhomocysteinemia as independent risk factor 2006 april
194 Coronary circulation 2008 april
RS
195 Anatomy of conduction system of heart 2011 may RS
196 Pain transmission and modulation 2012 may RS
CHAPTER 19: SYMPTOMATOLOGY AND EXAMINATION
197 Discuss the etiology ,clinical features and management of
30 years old patient presenting with acute onset of
dyspnea (20)
2012 may RS
CHAPTER 20 :INVESTIGATIONS
198 Intravascular ultrasound 2009 may
12

13. RS
199 CT scan in cardiac diagnosis 2011 may
RS
200 Stress test 2016 nov
201 Myocardial perfusion imaging 2018 may
408 Intravascular ulrasound and coronary disease 2012 may
RS
CHAPTER 21: HEART FAILURE
202 Discuss the recent trends in etiopathogenesis and management of
congestive cardiac failure (20)repeat oct 2008.may 2010 rs
2007 sept
203 Discuss etiology ,clinical features and management of
congestive heart failure(20)
2008 april
204 Refractory heart failure 2008 april
205 Newer treatment modalities in heart failure 2008 oct RS
206 Management of refractory heart failure 2009 may RS
207 Neurohormonal activation and compensatory mechanisms in
heart failure
2011 may RS
208 Diastolic heart failure /heart failure with preserved systolic
function
2013 nov
CHAPTER 22 :CONGENITAL HEART DISEASE
209 Explain development of embryological interatrial septum and biefly
classiy types of ASD and their management
200
6
sept
210 Describe the embryology of the heart and the anatomical basis of
development of Ebstein’s anomaly (20)
201
1
nov
RS
CHAPER 23 : HYPERTENSION AND ISCHEMIC HEART DISEASE
HYPERTENSION
211 Discuss the current views on the etiopathogenesis of the essential
hypertension and discuss primary prevention of it(20)
2007 april
212 Discuss hypertensive crisis management 2010 may
213 Renin inhibitors 2010 oct
214 Randomized clinical rials in hypertension 2010 oct
215 Hypertensive emergencies. Repeat nov 2017 2011 may
216 What are the hypertensive emergencies? Discuss etiology,
pathogenesis, clinical features,
complications and the management of hypertensive
emergencies(20)
2011 nov
217 Drug therapy of hypertensive emergenices 2012 nov rs
218 Ambulatory blood pressure monitoring 2015 may
219 Define hypertension .discuss the approach to management of
newly diagnosed hypertensive patient
2017 may
13

14. ISCHEMIC HEART DISEASE
220 Describe in detail the pathogenesis of atherosclerosis repeat nov
2012 RS
2012 nov
221 Describe anatomy of coronary arterial circulation .briefly discuss
non invasive diagnosis of myocardial infarction(20)
2014 may
222 Outline the physiology of coagulation and describe the
pathophysiology of acute coronary syndromes (20)
2015 may
223 Discuss recent trends in management of Acute myocardial
infarction(20)
2010 may
224 Discuss the etiology ,clinical features, evaluation and
management of unstable angina (20)
2009 may
RS
225 aherosclerosis and plaque progression 2009 may
RS
226 Discuss vasospastic angina 2008 oct
227 Discuss acute coronary syndromes and management of STEMI
.add a note on fibrinolysis versus PTCA (20)
2008 april
RS
228 Management of unstable angina 2007 sept
229 Mechanism of diastolic dysfunction in hypertrophic and ischemic
heart disease
2016 jun
230 Describe the clinical ,ECG, Echo diagnosis of right ventricular
infarction and its management
2007 april
231 Thrombolytic agents 2017 nov
232 Management of NSTEMI 2018 may
CHAPTER 24: ARRYTHMIAS
234 Discuss the anatomy and blood supply of AV conduction system
and write briefly various clinical disorder of AV conduction and
their management (20)
2006 april
235 etiologies of atrioventricular block 2016 jun
236 Non pharmacological management of atrial fibrillation 2008 april
RS
237 Antiarrythmic drugs 2010 may RS
238 Anti arrythmic drugs to prevent recurrence of atrial fibrillation 2010 oct
239 Pacemaker therapy in myocardial infarction 2011 nov
240 Genetically – determined arrhythmia syndromes 2011 may RS
241 Brugada syndrome 2012 nov
242 Pacemakers 2013 may
243 Discuss the evaluation, pathogenesis and management of 40 year
old man with atrial fibrillation (20)repeat may 2017
2015 may
CHAPTER 25 : VALVULAR HEART DISEASE
244 Define, classify infective endocarditis, discuss the
pathognesis,clinical diagnosis and management of prosthetic
valve endocarditis (20)
2006 sept
245 Management of infective endocarditis 2008 april
246 Discuss the etiology ,clinical features and diagnostic criteria of 2008 oct RS
14

15. infective endocarditis. write a note on surgical management of
infective endocarditis (20)
247 Discuss right sided endocarditis 2008 oct
248 Rheumatic chorea 2008 oct
CHAPTER 26 : CARDIOMYOPATHY
249 Classify Cardiomyopathies. Mention the Hemodynamics ,clinical
features and management of hypertrophic obstructive
cardiomyopathy (HOCM)(20)
200
8
april
250 Discuss aetiology, pathogenesis, clinical features, diagnosis &
management of hypertrophic obstructive cardiomyopathy(20)
201
1
nov
RS
251 Discuss etiology, clinical features ,management of restrictive
cardiomyopathy and differences between restrictive cardiomyopathy
and constrictive pericarditis repeat oct 2015,nov 2017
200
8
oct
252 Pathogenesis .clinical features and treatment of endomyocardial
fibrosis repeat jun 2016
200
6
april
253 Define cardiomyopathy. Discuss pathophysiology, clinical features
and management of dilated cardiomyopathy(20)
201
6
nov
254 Drug induced cardiomyopathy 201
2
nov
rs
255 Peripartum cardiomyopathy 201
7
may
CHAPTER 27: DISEASES OF PERICARDIUM
256 Discuss chronic consrictive pericarditis (20) 2011 may
CHAPTER 28 : HEART TUMORS,RHEUMATOID DISEASES OF HEART
,TRANSPLANTATION ,DISEASES OF AORTA AND PERIPHERAL VASCULAR
DISEASES
257 Cardiovascular manifestations of nutritional disorders 2011 may RS
258 Stem cell transplantation in cardiovascular medicine 2014 nov
SECTION 10 : GASTROINTESTINAL TRACT ,LIVER AND PANCREAS
CHAPTER 29 : SYMPTOMATOLOGY AND EXAMINATION
259 Approach to case of jaundice 201
0
may
RS
CHAPTER 30 : INVESTIGATIONS
CHAPTER 31 : GASROINTESTINAL TRACT
260 Barrets esophagus 2011 may
261 Pathophysiology and diagnosis of non – ulcer dyspepsia 2011 may
RS
15

16. 262 Infectious oesophagitis 2012 nov rs
263 Diagnosis and treatment of obscure gastrointestinal bleeding 2015 may
264 Discuss the evaluation and management of 50 yr old patient
presenting with hematemesis (20)
2015 oct
265 Management of bleeding esophageal varices 2016 jun
266 Achalasia cardia 2015 oct
267 Discuss the role of H pylori infection in GI disorders and its
management . Repeat nov 2016,may 2018
2006 sept
268 H pylori infection - current status 2007 sept
269 Natural history of helicobacter pylori infection 2010 oct
270 Causes and treatment of ulcers NOT CAUSED by H. pylori and
NSAIDS
2011 nov
271 What do you understand by the term "functional gastrointestinal
disorders" and discuss the clinical diagnosis and management of
irritable bowel syndrome (20)repeat april 2008 RS
2007 april
273 Describe the pathogenesis ,diagnosis and treatment of carcinoid
syndrome . Repeat april 2008
2007 april
273 Refractory ascites 2008 april
274 Extra - articular manifestations of ulcerative colitis 2008 oct
RS
275 Etiopathogenesis ,pathology and Management of ulcerative
colitis repeat may 2017(20),may 2018
2009 may
RS
276 Recent advance in the management of inflamatory bowel diseases 2010 oct
277 Extra intestinal manifestations of inflammatory bowel disease 2011 nov
278 Treatment of inflammatory bowel disease 2012 nov rs
279 Discuss etiopathology, clinical features ,diagnosis and treatment
of inflamatory bowel diseases
2013 nov
280 Crohns disease 2014 may
281 Discuss gastrointestinal motility 2015 may
282 Write the causes of diarrhea .describe the clinical features
,investigation, approach and treatment of malabsorption in india.
Nov 2016,may 2018
2015 may
283 Celiac disease repeat nov 2016 2014 may
284 protein losing enteropathy 2013 nov
285 Probiotics 2013 may
286 Gasrointestinal hormones repeat nov 2017 2013 may
287 Discuss the aetiology, clinical features and management of food
poisoning
2012 nov rs
288 Discuss the evaluation and management of 30 years old patient
presenting with chronic diarhoea (20)
2012 may
RS
289 . Describe in detail the gastrointestinal manifestations of parasitic
infections(20)
2011 may
RS
290 Progressive somatic mutational steps in the development of
colonic carcinoma
2011 may
RS
291 Short bowel syndrome repeat nov 2017 2011 may
292 Test's of malabsorption 2010 oct
293 Discuss newer proton pump inhibitors 2010 may
294 Discuss irritable bowel syndrome 2008 oct
295 Tropical sprue repeat (may 2010),nov 2011 2008 oct
16

17. RS
296 small intestinal mucosal biopsy in diagnosis of malabsorptive
states
2016 jun
297 Gastrointstinal neurondocrine tumors 2016 nov
CHAPTER 32: LIVER AND GALL BLADDER
29
9
Discuss about the liver function test in health and diseases(20) 2010 oct
30
0
Discuss the hepatorenal syndromes and their management (20) 2006 april
30
1
Discuss about non alcoholic steatohepatitis and its management 2006 sept
30
1
what are autoimmune liver diseases?discuss clinical
,biochemical, radiological, hisological criteria and management
of the same (20) repeat nov 2012 RS,nov 2013
2006 sept
30
3
Describe pathogenesis ,clinical features of amebic liver abscess
and its management
2007 april
30
4
diagnosis and Treatment of hepatitis b infection repeat may
2013,may 2015
2007 sept
30
5
compare different modalities in treatment in chronic hepatitis B
infection
2008 oct RS
30
6
Define autoimmune hepatitis .Describe the
immunopathogenesis ,clinical features and treatment of
autoimmune hepatitis(20) repeat april 2008 RS,nov 2011,nov
2012
2008 april
30
7
Discuss etiology ,pathology, clinical features and management of
NASH (non alcoholic staeato hepatitis )repeat may 2010
Rs,may 2012 RS,may 2013,nov 2013 Rs,nov 2017
2008 oct
30
8
Hepatorenal syndrome 2009 may RS
30
9
Discuss the etiology ,pathology, clinical features, invesigations
and management of hepatocellular carcinoma
2010 may
31
0
Clinical features and treatment of primary biliary cirrhosis 2011 nov
31
1
Discuss the metabolism of bilirubin and approach to patient with
hyperbilirubinemia
2012 may RS
31
2
Non cirrhotic portal hypertension 2012 may RS
31
3
Budd chiari syndrome 2013 may
31
4
current management of chronic hepatitis c infection 2017 nov
31
5
Wilsons disease 2017 nov
31
6
Pathology of chronic hepatitis 2018 may
31
7
Drug induced liver injury /hepatotoxicity of drugs 2018 may
31 Non cirrhotic portal fibrosis 2006 april
17

18. 8
31
9
Management of portal hypertension 2008 april
32
0
Clinical features, complications and Medical management of gall
stone . Repeat may 2017
2006 april
CHAPTER 33 : PANCREAS
321 Pancreatic ascites 2006 april
322 Complications of acute pancreatitis repeat jun 2016 2008 april RS
323 Discuss the etiology ,clinical features and management of
acute pancreatitis(20)
2015 oct
324 Risk stratification in acute pancreatitis 2011 nov RS
325 Chronic pancreatitis 2010 may RS
VOLUME 3
SECTION 11 : RESPIRATORY SYSTEM
CHAPTER 34 : ANATOMY AND PHYSIOLOGY
326 Bronchopulmonary segments 201
2
nov
CHAPTER 35 : HISTORY AND EXAMINATION
327 Describe how each of the following symptoms relates to
disease of the lung and describe the source of symptom
cough and sputum production ,dry cough wheeze,snore
,shortneess of breath with exercise ,confusion
2015 may
CHAPTER 36 : INVESTIGATIONS
328 Bronchioalveolar lavage 201
2
may
RS
329 pulmonary function tests 201
3
may
330 Ventilation perfusion matching 201
7
nov
CHAPTER 37: OBSTRUCTIVE LUNG DISEASES
18

19. 331 Leukotreine receptor antagonist and their role in management of
bronchial asthma
2007 april
332 Write recent trends in management of bronchial asthma (20) 2008 april
333 Emerging therapies in bronchial asthma 2008 oct
RS
334 Discuss leukotreine receptor anagonists 2008 oct
335 Clinical features and management of acute severe asthma 2008 oct
336 Pulmonary biomarkers of COPD 2012 nov rs
337 GOLD guidelines for management of COPD 2017 nov
338 Discuss the etiopathogenesis,clinical features,diagnosis
,complications and management of bronchiectasis (20)
2008 oct
CHAPTER 38: DPLD,ILD AND ALLERGIC LUNG DISEASES
339 Discuss the etiology, pathogenesis , diagnosis and management
of interstitial lung disease (20)
2008 april
340 Discuss diagnosis of sarcoidosis 2008 april
341 Describe the etiopathogenesis , clinical features, diagnosis and
management of sarcoidosis repeat nov 2016
2006 april
342 Lis the chronic granulomatous diseases.d escribe the pathology
of sarcoidosis and write briefly on laboratory invesigations.(20)
2011 may
343 Calcium metabolism in sarcoidosis 2011 nov
344 Tropical pulmonary eosinophilia repeat may 2010 RS,may
2017
2007 sept
345 Allergic Bronchopulmonary aspergillosis repeat may 2018 2008 april RS
346 Eosinophillic lung disease repeat may 2015 2010 may
347 Hypersensitivity pneumonitis repeat nov 2013,nov 2016 2010 oct
348 Farmer's lung repeat nov 2013 2010 oct
349 Silicosis 2010 may RS
350 Asbestosis 2011 may
351 Pulmonary manifestations of connective tissue diseases 2011 may RS
352 Discuss the differential diagnosis of a 55 year old female
labourer presenting with progressive dyspnea ,clubbing and fine
end inspiratory crackles on lung auscultation .how to evaluate
her and arrive at diagnosis
2014 may
353 Pathophysiology and management of idiopathic pulmonary
fibrosis
2017 may
354 Beryliosis 2018 may
CHAPTER 39 : DISEASES OF PULMONARY VASCULATURE AND DVT
355 Discuss etiology ,clinical features and management of
pulmonary arterial hypertension(20) repeat may 2015
2007 sept
356 pulmonary hypertension treatment details 2008 april RS
357 Drug therapy of pulmonary hypertension 2012 may RS
358 Discuss clinical features, diagnosis and management of acute
pulmonary embolism .repeat may 2018
2006 sept
359 Pulmonary embolism diagnosis and management repeat may
2015
2008 oct RS
19

20. 360 Discuss oral anticoagulant therapy 2008 oct
361 Dabigatran etexilate drug 2011 nov
362 Describe etiology, pathophysiology, clinical features,
diagnosis, complications and treatment of
acute pulmonary embolism(20) repeat nov 2011 rs
2011 nov
363 Discuss the evaluation and treatment of deep vein thrombosis
(20)
2016 jun
364 Thrombophillia 2016 nov
365 Imaging in pulmonary thromboembolism 2017 may
366 Wells diagnostic scoring for suspected pulmonary embolism 2017 may
CHAPTER 40 : INFECTIONS OF RESPIRATORY TRACT
367 Define community acquired pneumonias, mention the causes
and their management (20)
2006 april
368 Approach to patient with community acquired pneumonia 2008 april RS
369 Hospital acquired pneumonia 2008 oct RS
370 Name the organisms causing health care associated
pneumonia .Discuss the clinical features ,complications and
management of pseudomonas pneumonia (20)
2009 may RS
371 Discuss etiology, clinical features, investigation and treatment
of community acquired pneumonia
2010 may
372 Factors predisposing to nosocomial pneumonia 2010 oct
373 Etiopathogenesis , epidemology ,Clinical features ,
extapulmonry manifestations and management of pneumonia
due to mycoplasma(20)repeat jun 2016
2011 may RS
374 Assessment of disease severity and microbiological
investigations in community acquired pneumonia
2014 may
375 Ventilator associated pneumonia 2017 nov
376 Discuss the diagnosis and management of milliary tuberculosis 2006 sept
377 Discuss the drug resistance in a patient of tuberculosis .How do
you manage multi drug resistance tuberculosis ?(20) repeat
may 2014,nov 2017
2007 sept
378 Discuss nosocomial pneumonia 2008 april
379 clinical features ,investigation and treatment of influenza A
H1N1 infection repeat nov 2013 ,may 2015
2010 oct
380 Treatment of pulmonary fungal infections 2011 may
381 Pulmonary manifestations of aspergilosis 2015 oct
382 write an essay on parasitic diseases of lungs(20) 2006 sept
CHAPTER 41: DISEASES OF PLEURA AND LUNG TRANSPLANT
383 Diagnostic approach to pleural effusion 2010 may RS
384 Causes, clinical features, diagnosis and treatment of chylothorax 2011 nov
385 Lung transplant 2011 nov RS
CHAPTER 42 : OSA AND HYPOVENTILATION
386 Hypoventilation syndrome - etiopathogenesis ,clinical 2010 may RS
20

21. featurs,diagnosis and management repeat may 2013 nov
2013
387 Discuss sleep apnea (20) etiology evaluation , complications
repeat may 2013,nov 2016
2011 may
CHAPTER 43 :TUMORS OF LUNG
388 Coin shadow /pulmonary nodule in X ray chest repeat nov
2017
2010 may
389 Describe etiology, pathology, clinical manifestations,
diagnosis, staging and treatment of lung
cancer
2011 nov
390 Bronchial carcinoid 2012 may RS
391 Thoracic outlet compression syndrome 2012 nov rs
392 Superior venacaval obstruction 2014 nov
CHAPTER 44: COLLAPSE AND OTHERS
SECTION 12: CENTRAL NERVOUS SYSTEM
CHAPTER 45 : ANATOMY AND PHYSIOLOGY
393 Draw the diagram of circle of willis and its role in dynamics
of cerebral circulation and its disorders
2006 april
394 Describe anatomy of Cerebral circulation. Discuss etiology
of sroke in young .repeat nov 2013 RS
2008 oct RS
395 What structures constitute basal ganglia ?discuss the clinical
features of basal ganglia lesions(20)
2009 may RS
396 Innervation of urinary bladder 2010 oct
397 Limbic network of memory 2011 nov
398 Blood supply of brain 2012 nov
399 Explain the formation and circulation of cerebrospinal fluid
and its clinical application
2015 may
400 Neuroanatomy and blood supply of internal capsule 2016 nov
401 Describe the innervation of urinary bladder and outline the
varaious type of neurogenic bladder encountered in clinical
practice (20)
2017 may
CHAPTER 46 : HISTORY AND EXAMINATION ,COMA,HEADACHE,SEIZZURES
AND DEMENTIA
402 management of migraine repeat may 2014 2008 april
403 Reversible dementias 2008 april
RS
21

22. 404 Alzheimer's disease pathophysiology,diagnosis and treatment
repeat oct 2010
2010 may
405 Clinical approach to amnesia 2014 may
406 Discuss etiology,clinical features and management of dementia
in elderly (20)
2015 oct
407 Clinical features and management of delirium 2018 may
CHAPTER 47 : INVESTIGATIONS
409 Discuss ring enhancing lesions in central nervous system 2015 oct
CHAPTER 48 :CELLULAR PATHOLOGY
CHAPTER 49 & 50: CERBRAL EDEMA ,HYDROCEPHALUS AND
MALFORMATIONS
410 Normal pressure hydrocephalus 2017 nov
CHAPTER 51 : CEREBROVASCULAR DISEASES
411 Discuss the anatomy of vertebro basilar artery system .discuss
the various stroke syndromes associated with vertbro basilar
circulation (20)
2006 sept
412 Neuronal protection in stroke repeat 2009 may RS 2006 sept
413 Discuss the management of ischaemic neurological stroke in
he first 24 hrs (20)repeat april -2008
2007 april
414 Discuss the role of thrombolysis in stroke .write a note on the
adminstration of thrombolytic agent rTPA in acute ischaemic
sroke (20)
2008 april RS
415 Discuss the circle of willis. discuss the clinicoanatomical
correlation of wallenbergs syndrome and is management
2012 may RS
416 Lacunar stroke syndromes 2017 nov
417 Approach to stroke in young 2014 nov
418 Discuss aetiology , pathogenesis, clinical features, diagnosis
& management of hemorrhagic
stroke
2012 nov rs
419 Discuss etiology, clinical features ,diagnosis and management
of cerebral venous infarction .repeat nov 2016
2013 nov
420 Discuss the clinical approach of a 25 year old woman ,who
had delivered 15 days back and develops paraparesis over a 12
hour period (20)
2014 may
421 Management of subarachnoid hemmhorhage 2010 may RS
CHAPTER 52 : CNS INFECTIONS
22

23. 422 Discuss neurological manifestations of HIV/AIDS diagnosis
and management (20)
2008 april RS
423 Discuss etiology, clinical features ,diagnosis and treatment of
pyogenic meningitis repeat may 2018
2015 may
424 Aseptic meningitis 2013 may
425 Recurrent meningitis 2008 oct RS
426 Chronic meningitis 2010 may
427 Describe in detail the neuropsychiatric manifestations of
infectious diseases (20)
2010 oct
428 Enumerate the zoonoses seen in the tropics. Outline the
neurological manifestations of each
2011 may RS
429 Tabes dorsalis 2012 nov
CHAPTER 53: PRIONS
430 what are prions? How do they cause disease? 2007 sept
CHAPTER 54 : DEMYELINATING DISEASES
431 Discuss the role of immunoglobulins and plasmapharesis in
neurology
2006 april
432 Variants of gulian bare syndrome Repeat jun 2017 2007 sept
433 Discuss the immunopathogenesis ,clinical features ,diagnosis
and management of multiple sclerosis (20)repeat may 2009
RS,may 2010 RS,may 2012 RS,nov 2013
2008 oct
434 Anatomical basis of one and half syndrome 2017 may
523 How will you approach a case of acute myelopathy ? Add a note on
recurrent myelits (20)
2008 oct
RS
CHAPTER 55 : METABOLIC AND GENETIC DISEASE
435 Acute alcohol intoxication and its management 200
6
sept
436 Discuss the various nutritional neurological disorders in india (20) 200
7
sept
437 Discuss neurological complications of chronic alcoholism 200
8
oct
CHAPTER 56 : MOVEMENT DISORDERS
438 Discuss the current advances in the management of parkinsons
disease (20)
200
6
april
439 Modern management of Parkinsonism 200
7
sept
440 Classify dystonia .Discuss the pathophysiology ,clinical features and
management of dystonia(20)
200
9
may
RS
441 Discuss the etiopathogenesis ,clinical features and management of
parkinson's disease repeat nov 2014
201
0
may
23

24. 442 Classify and discuss the pathophysiology of movement disorders.
discuss the treatment of parkinson's disease(20)
201
1
may
443 Cabergoline 201
1
nov
444 Etiology, clinical features and treatment of Huntington’s disease
repeat 2016 july
201
1
nov
445 Outline the cascade of pathogenetic events leading to neuronal cell
death in parkinson’s disease.Critically analyse the role of
neuroprotective therapy in akinetic rigid syndromes(20)
201
1
may
RS
446 Classify hyperkinetic movement disorders, discuss aetiology, clinical
features, diagnosis and management of various types of choreas(20)
repeat july 2016
201
1
nov
RS
CHAPTER 57 :TUMORS
CHAPTER 58: EPILEPSY
447 Discuss role of surgery in epilepsy management 200
6
april
448 Newer aniconvulsant drugs 200
7
april
449 Refractory seizure/epilepsy repeat may 2018 200
7
april
450 Discuss temporal lobe epilepsy 200
8
april
451 Classify anticonvulsants .Discuss the evaluation and
pharmacotherapy of complex partial seizures(20)
200
9
may
RS
452 Management of staus epilepticus 201
0
may
RS
453 Investigation of seizures disorders 201
0
oct
454 Treatment of refractory epilepsy 201
1
nov
455 Modes of action and side effects of anticonvulsants 201
1
nov
RS
456 Status epilepticus 201
5
may
457 Clinical profile of hot water epilepsy and management 201
7
may
CHAPTER 59 :DISORDERS OF PERIPHERAL NERVE
458 Critical illness neuropathy 2011 may
459 Discuss the approach to a patient with peripheral
neuropathy(20)
2012 nov
460 Orthostatic hypotension 2012 nov rs
CHAPTER 60 : DISORDERS OF NEUROMUSCULAR JUNCTION AND MOOR
NEURON DISEASE
24

25. 461 Familial periodic paralysis 2008 april
462 Describe the classification ,etiopathogenesis ,diagnosis and
management of motor neuron disorders.outline the genetic motor
neuron disease (20)
2010 oct
463 Congential myasthenic syndromes 2011 may
RS
464 Myasthenia gravis -etiopathogenesis, clinical features and
management .repeat nov 2017
2015 oct
CHAPER 61: DISEASES OF SKELETAL MUSCLE
464 Myasthenia gravis -etiopathogenesis,clinical features and
management .repeat nov 2017
2015 oct
465 Endocrine myopathies(20) 2007 sept
466 polymyositis 2010 may
467 Musculoskeletal abnormalities in endocrine disorders 2011 may
RS
468 Describe the immunopathogenesis and cell mediated mechanisms
of muscle damage in inflamatory myopathies .outline the criteria
for diagnosis and management (20)
2017 may
CHAPTER 62 : CRANIAL NERVE
469 Describe the anatomy of 7th nerve and briefly mention various
disorders affecting it functions
2006 sept
470 Describe the course of 7th cranial nerve and discuss the etiology
and clinical features of 7th cranial nerve palsy (20)
2010 oct
471 Trigeminal neuralgia 2011 nov
RS
472 Skin lesions produced by microorganisms that are known to
affect the fascial nerve
2014 may
CHAPTER 63 : SPINAL CORD AND CERVICAL SPONDYLOSIS
473 Spinal cord anatomy and blood supply 2010 may RS
474 Discuss etiology, pathophysiology, clinical features,
investigations and treatment of non compressive
myelopathies(20)
2011 nov
CHAPTER 64: BRAIN DEATH
475 Brain death 2012 nov
rs
SECTION 13: RHEUMATOLOGY
CHAPTER 65: RHEUMATOLOGY
476 Discuss disease modifying drugs in Rheumatoid arthritis repeat
may 2018
200
8
april
477 Discuss the clinical features, diagnosis and recent concepts in 200 oct RS
25

26. management of rheumatoid arthritis(20) 8
478 Recent concepts in management of rheumatoid arthritis 200
8
oct
479 Biological agents for treatment of rheumatoid arthritis repeat
may 2014,oct 2015
201
1
may
480 Early rheumatoid arthritis 201
4
nov
481 Define rheumatoid arthritis .discuss etiopathogenesis ,clinical
features and management (20)
201
5
may
482 Malignant rheumatoid arthritis 201
6
jun
483 Hydroxychloroquine 201
6
nov
484 Define lupus. Discuss etiopathogenesis ,clinical features,
diagnosis and treatment of systemic lupus erythematosus(20)
201
5
oct
485 Discuss antiphospholipid syndrome. repeat nov 2016,nov 2017 201
2
nov
486 Discuss classification, clinical features and management of
lupus nephritis rPeat nov 2012 rs,nov 2016
200
8
april
487 Discuss the clinical features and criteria for SLE .draw an
algorithm for diagnosis and initial therapy of SLE(20)
200
8
april RS
488 Clinical utility of autoantibodies in systemic lupus
erythematosus
200
9
may RS
489 Describe the diagnosis and management of progressive systemic
sclerosis . Repeat nov 2012 RS
200
6
april
490 Describe the diagnostic criteria for sjogren's syndrome
,distinguish sjogren's syndrome from HIV infection /sicca
syndrome and sarcoidosis .outline the treatment algorithm for he
disease based on clinical features (20)
201
0
oct
491 Mixed connective tissue diseases repeat jun 2017 201
1
may
492 Pulmonary features of systemic sclerosis 201
1
nov
493 Sjogren’s syndrome etiology ,diagnosis and management repeat
may 2013
201
1
nov RS
494 Systemic sclerosis 201
2
nov rs
495 Raynauds phenomenon 201
5
oct
496 seronegative arthritis -etiopathogenesis ,clinical
features,diagnosis and management repeat nov 2016
200
6
sept
497 Ankylosing spondylitis repeat nov 2013 200
7
april
498 Infliximab 200
7
april
499 Reiter's disease 200
7
sept
500 Psoriatic arthritis repeat may 2010 200
8
april
501 Enumerate the sero negative spondyloarthropathies .describe the
clinical features, diagnosis and management of ankylosing
201
0
may RS
26

27. spondylitis(20)
502 Reactive arthritis repeat may 2012 RS 201
0
may
503 Describe in detail he ocular manif estations of conneective tissue
disorders
201
7
may
504 Jaccouds arthritis 201
8
may
CHAPTER 66 : VASCULITIS
505 Discuss the values of anti neutophilic cytoplasmic anibodies in
clinical rheumatology
2006 april
506 ANCA associated diseases/vasculitis repeat may 2015, nov
2016
2007 april
507 Polyaeritis nodosa 2008 oct
508 Diagnosis and management of Churg strauss syndrome 2009 may RS
509 Takasau's arteritis 2011 may
510 Discuss the pathogenic mechanisms of vessel damage in
vasculitic syndromes and approach outline the
diagnosis and clinical features of small vessel vasculitis
repeat july 2016,nov 2016
2011 may RS
511 Evaluation of aortic arteritis 2012 may RS
512 Bechets syndrome 2013 nov
513 Wegners granulomatosis repeat nov 2017 2014 nov
SECTION 14 : DISEASES OF GENITAL TRACT
CHAPTER 67 : SEXUAL MEDICINE
514 Investigation in male infertility 2006 april
515 Gynecomastia 2008 april
516 Tesosterone replacement therapy 2008 april RS
517 Polycystic ovarian syndrome 2008 oct RS
518 Evaluation and management of erectile dysfunction repeat
2011 mayRS,may 2012 RS,nov 2013
2009 may RS
519 Postmenopausal hormone replacement therapy 2010 may RS
520 Evaluation of gynecomastia 2010 oct
521 Hirsutism repeat nov 2016 2011 nov RS
522 Androgen replacement therapy 2013 may
SECTION 15 : DISEASES OF BONE AND JOINT
CHAPER 68 : METABOLIC DISEASE OF BONE ,ARTHRITIS ,INFECTIONS OF
BONE AND JOINTS
524 Discuss diagnosis and treatment of Gout 2008 april
525 Management of osteoporosis repeat nov 2013 2008 april RS
526 Measurement of bone mass 2009 may RS
527 Investigation of osteoporosis 2010 oct
27

28. 528 Discuss definition, epidemiology, pathophysiology, clinical
features, diagnosis and treatment of osteoporosis(20) repeat
nov 2012 RS
2011 nov
529 Clinical features of syndromes associated with Hypoxanthine –
Guanine – Phosphoribose _Transferase (HGPRT) deficiency
2011 may RS
530 Outline the uric acid pool mentioning the factors relating to
crystal formation and tissue concentration at any one time.
2011 nov
531 Enumerate factors predisposing to hyperuricemia and gout and
describe its long – term management
2011 nov RS
532 Paget’s disease of bone 2011 nov RS
533 Crystal associated arthritides- etiopathognesis and management
.repeat may 2014,july 2016
2012 nov
534 Management of gout 2012 nov rs
535 discuss the evaluation and management of 40 year old female
presenting with polyarthritis of 4 months duraion(20)
2013 may
536 Etiology ,clinical characterstics Management of osteoarthritis
repeat may 2014
2010 may RS
PAPER 4
SECTION 16 : NEPHROLOGY
CHAPTER 69 : ANATOMY AND PHYSIOLOGY
537 Discuss anatomy and physiology of nephron (20) 2008 oct
538 Discuss role of renin angiotensin system in health and disease
and drugs (20) repeat nov 2016
2015 oct
539 Regulation of arginine vasopressin secretion 2017 nov
CHAPTER 70 : HISTORY,EXAMINATION AND INVESTIGATIONS
540 Relevance of examination of urine in diagnosis of renal
disorders
2006 sept
541 Approach to a case of hematuria 2008 oct RS
28

29. 542 Discuss the evaluation and management of 30 years old non
diabeic patient presenting with albuminuria (20) repeat oct 2010
2010 may RS
CHAPER 71 : GLOMERULAR DISEASES
543 Classify lupus nephritis and briefly mention its management 200
6
april
544 Kidney lesions in SLE 200
6
sept
545 IgA nephropathy repeat nov 2017 201
1
may
546 C1q nephropathy 201
2
may
RS
547 Rapidly progressive glomerulonephritis 201
3
may
548 Discuss etiopathology,clinical features ,diagnosis and treatment of
acute glomerulonephritic syndromes(20)
201
7
may
CHAPTER 72 : AKI AND CKD
550 Distinction between prerenal, and intrinsic causes of renal
dysfunction
2011 may RS
551 Nondialytic management of end stage renal disease 2006 sept
551 Define chronic renal failure /end stage renal disease .discuss
etiology clinical features and management (20)
2015 oct
552 Discuss the pathogenesis ,diagnosis and management of acute
renal failure/AKI (20) repeat april 2008,nov 2011,may 2018
2007 april
553 Renal osteodystrophy repeat july 2016,NOV 2012 2008 oct RS
CHAPTER 73 : TUBULAR DISEASE
554 Nephrotoxicity of drugs 2007 sept
555 Renal tubular acidosis clinical approach and diagnostic
evaluationrepeat oct 2008 ,may 2013,may 2014,oct 2015
2008 oct RS
556 Drug induced renal diseases 2015 may
CHAPTER 74 : VASCULAR DISEASE
557 Renovascular hyperension ,diagnosis and management(20)
repeat oct 2008
200
7
sept
558 Renal artery stenosis 200
8
april RS
CHAPTER 75 : CONGENITAL DISEASE
559 Alport’s syndrome nov 2012 RS 201
1
nov
560 Polycystic kidney disease 201
1
nov
29

30. CHAPTER 76 : OBSTRUCTIVE UROPATHY
561 Risk factors for nephrolithiasis 2017 nov
CHAPTER 77 : RENAL REPLACEMENT THERAPY
562 Immunosupressive therapy in renal transplanation 2009 may
RS
563 Discuss renal replacement therapy 2011 nov
RS
564 Indications and complications of dialysis in renal dysfunction 2014 may
565 Continous renal replacement therapy 2018 may
CHAPTER 78 : INFECTIONS
566 Asymptomatic bacteruria 2008 april
RS
567 Nongonococal urethritis 2012 may RS
SECTION 17 : ENDOCRINOLOGY
CHAPTER 79 :PHYSIOLOGY
CHAPER 80 : THYROID
568 Discuss the etiology ,clinical features ,diagnosis ,evaluation and
management of hypothyroidism .how will you manage
myxedema coma .repeat oct 2008 (20)
200
7
april
569 hashimotos disease 200
7
sept
570 Sick euthyroid syndrome REPEAT NOV 2011 200
8
april RS
571 Peripartum thyroidits 201
1
nov RS
572 Describe the etiology clinical features ,management of graves
disease add a note on thyrotoxicosis
201
3
may
573 Goitrous hypothyroidism 201
5
may
574 Deescribe the regulation of thyroid nhormone synthesis and
mchanism of thyroid receptor action .Mention conditions
associated with euhyroid hyperthyroxinemia and outline
pathophysiological basis of pendred syndrome (20)
201
6
jun
575 Subclinical thyroid dysfunction 201
6
jun
576 Management of emergencies in thyroid dysfunction 201
7
may
577 Myxedema coma 201
8
may
30

31. CHAPTER 81 : PARATHYROID
578 Discuss the etiology,clinical features and mnagement of
Hyperparathyroidism(20)
2009 may RS
579 Biochemical aberrations in primary hyperparathyroidism 2011 may RS
580 Pseudohypoparathyroidism 2014 may
CHAPTER 82 : ENDOCRINE PANCREAS
DIABETES
581 Guidelines for ongoing medical care in patients with diabetes
mellitus
2010 oct
582 Describe genetic inheritence of type 2 dm 2006 april
583 Classify diabetes mellitus and discuss recent advances in
management of diabetes mellitus
2006 april
584 Discuss various abnormalities that characterize endothelial
dysfunction in diabetes mellitus
2006 sept
585 Diagnosis of diabetes mellitus ,recent concepts in etiology ,its
pathogenesis (20)
2006 sept
586 Insulin receptor 2007 april
587 Describe in detail the calculation of calorie requirment of a type
2 diabetic who weighs 90 kg and 160 cm tall.describe the
various quantities of macronutrients and planning of his meals
2007 sept
588 Diabetic nephropathy pathogenesis,clinical
features,diagnosis,treatment and its prevention repeat may
2012RS,nov 2012
2007 sept
589 Mention causes of coma in diabetes .Discuss etiology ,
pathophysiology,clinical features and management of Diabetic
ketoacidosis and its complications (20)repeat RS
april2008,may 2010
2008 april
590 Dermatological manifestations of diabetes repeat may 2010
RS
2008 oct RS
591 Diabetic autonomic neuropathy repeat may 2010 2008 oct
592 Discuss maturity onset diabetes in young (MODY) 2008 oct
593 Evaluation of diabetic foot 2009 may RS
594 Molecular mechanisms of diabetes related complications 2011 may RS
595 Incretins repeat nov 2017 2012 nov
596 Metformin revisited 2012 nov rs
597 Risk factors for developing and natural history of diabetic
nephropathy
2012 nov rs
598 Incretin – based therapies in diabetes mellitus 2012 nov rs
599 Insulin glargine 2013 may
600 Liraglutide 2013 nov
601 What is incretin effect ? What are incretins ? Discuss action of
incretomimetic drugs
2014 may
602 Discuss etiopathogenesis of diabetic complications .mention
intervenions available to retard them .(20)
2015 may
603 Newer insulins 2015 oct
604 DPP IV inhibition 2018 may
31

32. 605 Cardiovascular safety of DPPIV inhibitors 2018 may
OTHERS
606 Zollinger Ellison syndrome 201
2
nov
607 Discuss approach to hypoglycemia 201
5
oct
CHAPTER 83: ADRENALS
608 Cushing syndrome repeat nov 2017 2008 april
609 Medical adrenalectomy 2009 may
RS
610 Adrenal virillism 2010 oct
611 Discuss the pathogenesis ,clinical features ,investigation and
treatment of primary adrenocortical insufficiency
2011 may
612 Mechanisms and regulations of aldosterone secretion 2011 nov
613 Psychiatric manifestations of endocrine disorders 2012 nov rs
614 Congenital adrenal hyperplasia 2014 may
615 Pheochromocytoma 2015 oct
616 Discuss aldosteronism 2016 nov
617 Addisons disease repeat nov 2017 2017 may
CHAPTER 84 : PITUATORY AND MEN
618 Adult growth hormone deficiency 2008 oct RS
619 Diagnosis of diabetes insipidus 2010 may RS
620 Discuss disorders of neurohypophysis 2011 nov RS
621 Nephrogenic diabetes insipidus 2012 may RS
622 diagnosis of diabetes insipidus 2012 nov
623 Discuss the causes, clinical manifestations, investigations and
treatment of
Hyperprolactinaemia repeat jun 2017,may 2018
2012 nov
624 Iatrogenic cushing syndrome 2013 nov
625 Mention the causes of polyuria. Discuss clinical features and
management of nephrogenic diabetes insipidus (20)
2013 nov
CHAPTER 85 : METABOLIC DISEASES
626 Discuss familial hyperlipidemias 2006 april
627 Write essay on cardiovascular dysmetatrotic syndrome
(metabolic syndrome X )and its management (20)repeat
2007(10),may 2011 RS,may 2014
2006 april
628 Describe the apolipoprotein and their significance in disease
status
2007 sept
629 Hyperhomocystenemia 2009 may RS
630 Effects of statins on renal function 2009 may RS
32

33. 631 HDl cholesterol in health and disease 2009 may RS
632 Discuss the etiology ,evaluation,complication and management
of morbid obesity(20)
2009 may RS
633 Hemochromatosis 2011 nov RS
634 Apolipoprotein 2012 may RS
635 Hyper homocysteinemias 2012 nov
636 reecent conceps of drug treatment of hyprlipidemia 2014 may
637 Genetic syndroms and gens associated with obesity 2014 nov
638 Outline the enzymes of heme biosynthetic pathway and mention
the diseases associated with their defficeincies indicating mode
of inheritance(20)
2017 may
639 Low HDL and its management 2018 may
SECTION 18 : HEMATOLOGY
CHAPTER 86 : RBC
641 classify hmolyic anemias .Discuss the clinical features diagnosis
and managment of sickle cell disease repeat oct 2015
2006 april
642 Write an essay on various types of nutritional anaemias
encountered in the tropics (20)
2007 april
643 Sideroblastic anemias repeat nov 2011 2008 april
644 Pure red cell aplasia 2008 april
645 What are the adverse effects of blood transfusion .how will you
manage a case of blood transfusion reaction ?what are the
precautions you should take (20)
2008 april
RS
646 Discuss the approach to diagnosis of anaemia .how will you a
manage a male with hemoglobin of 8gm/dl (20)
2008 april
RS
647 Discuss the etiology of megaloblastic anemia .add a note on
diagnosis and its management
2008 oct RS
648 Discuss the clinical approach and management of
pancytopenia(20)
2008 oct
649 Autoimmunehemolytic anaemia repeat may 2011,nov 2017 2009 may
RS
650 Hemolytic uremic syndrome repeat may 2018 2010 may
RS
651 Post transfusion hepatitis 2010 may
652 Iron chelating therapy for transfusion iron overload 2011 may
653 schilling test 2011 nov
654 Treatment of autoimmune hemolytic anemia 2011 nov
655 Polycythemiavera 2011 may
RS
656 Inheritance of hereditary spherocytosis and its pathogenesis at
the molecular level
2011 nov
RS
657 Red cell exchange transfusion 2012 may
RS
658 Megaloblastic anemia 2012 nov rs
659 Blood component therapy repeat nov 2017 2013 may
660 Classify hemolytic anemias. outline the laboratory diagnosis of
hemolysis . Describe etiology , clinical features , diagnosis and
2014 may
33

34. recent concepts in the management of b thalassemia major (20)
661 Pernicous anemia -clinical features and management 2018 may
CHAPTER 87: WBC
662 Current trends of management of chronic myeloid leukemia 200
6
april
663 Discuss genetic inheritance ,diagnosis and treatment of beta
thalassemia
200
6
sept
664 Discuss myelodysplastic syndrome ,its etiology ,Who classification
clinical features diagnosis and management (20) repeat april
2007(10)oct 2010,nov 2013
200
6
sept
665 Treatment of infections in hematological malignancy 200
7
sept
666 Discuss the role of karyotyping in leukemias 200
8
oct
667 BCR -ABL gene 201
0
may
RS
668 Discuss genetics,clinical features,diagnosis and treatment of chronic
myeloid leukemia (20)
201
0
may
669 Clinical manifestations, diagnosis and treatment of systemic
mastocytosis
201
1
nov
670 Classify myelodysplastic syndromes Describe the pathophysiology,
clinical features, diagnosis and recent trends in the management of
myelodysplasias. Outline the international prognostic scoring system
of the diseases(20)
201
1
may
RS
671 Discuss the etiology ,clinical features and management of refractory
anemia
201
2
may
RS
672 Myeloproliferative neoplasms – classification, molecular basis,
diagnosis and management
201
2
nov
673 Waldenstroms macroglobulinemia 201
6
nov
674 Management of multiple myeloma 201
7
nov
CHAPTER 88 : PLATELETS
675 Hemarthrosis 2008 april
676 Discuss management of chronic immune mediated
thrombocytopenic purpura
2008 oct
677 Outline the coagulation cascade and describe the formation of
the haemostatic plug. Discuss The investigation of bleeding
disorders
2012 nov rs
678 What are the causes of thrombocyttopenia?discuss clinical
features ,diagnosis and treatment of immune thrombocytopenic
purpura
2017 may
679 TTP 2017 nov
SECTION 19: ONCOLOGY
34

35. CHAPTER 89 : PATHOLOGY AND CANCER GENETICS
680 Tumor markers repeat may 2010,may 2011,nov 2016 2008 april
RS
681 Tumor angiogenesis 2008 oct RS
682 Oncogenes 2011 nov
RS
CHAPTER 90: DIAGNOSIS AND PARANEOPLASTIC SYNDROMES
683 Mention the paraneoplastic neurologic syndromes.
Describe their clinical features and outline the anti –
neuronal antibodies and cancers associated with each
and treatment (20) repeat oct 2015,july 2016
2011 may RS
684 Isotope bone scan 2018 may
CHAPTER 91 : CHEMOTHERAPY
685 Classify oncologic emergencies and enumerate the treatment
–related oncologic emergencies.
Describe the clinical features. Biochemical aberrations and
management of tumor lysis
syndrome repeat nov 2017
2012 nov rs
686 Febrile neutropenia 2008 april RS
687 Monoclonal antibodies in oncology 2010 oct
688 Tumour lysis syndrome 2012 nov
689 Targeted therapy 2015 oct
670 Monoclonal antibodies in medicine 2016 jun
CHAPTER 92 : RADIOTHERAPY
CHAPTER 93:SOLID TUMORS
CHAPTER 94: BONE MARROW TRANSPLANTATION,STEM CELL
TRANSPLANTATION AND GENE THERAPY
671 Bone marrow transplantaion:indications,procedure and
preparation of patient (20)
200
7
sept
672 Stem cell transplantation- hematopoetic and other uses repeat
may 2013, may 2014,may 2015
201
0
may RS
673 Tissue engineering 201
1
may RS
674 Describe the cloning of genes. Discuss gene therapy for cancer.
Add a note on stem cell therapy in Diabetes
201
2
nov
SECTION 20 : PSYCHIATRY
CHAPTER 95 : HISTORY AND EXMN
35

36. CHAPTER 96: SCHIZOPHRENIA AND RELATED DISORDERS
675 Schizophrenia 201
2
nov
676 etiopathogenesis ,Diagnosis and management of acute schizophrenia
repeat jun 2017
201
5
may
677 Mention first rank symptoms of schizophrenia .what afre the
differential diagnosis of schizophrenia ?
201
8
may
CHAPTER 97 : DEPRESSION AND MANIA
678 Discuss common antidepressanst drugs used in clinical practice 2006 sept
679 Major depressive episode -diagnosis and treatment 2008 oct
RS
680 Newer antidepressants 2010 oct
CHAPTER 98 : OTHERS
681 post traumatic stress disorder 2016 nov
682 Discuss various somatoform disorder and their management
repeat nov 2011
2007 april
683 Somatisation disorder 2008 april RS
684 Fibromyalgia 2011 nov RS
685 Chronic fatigue syndrome repeat may 2014 2012 nov rs
686 anorexia nervosa 2009 may RS
687 Narcolepsy 2012 nov
688 Diagnosis and Therapy of alcohol dependence repeat may
2013
2009 may RS
689 Management of substance abuse 2012 may RS
690 Neuroleptic malignant syndrome 2006 sept
691 Cognitive psychotherapy 2007 sept
SECTION 21 : DERMATOLOGY
692 Purpura fulminansa 2011 may
693 Discuss the approach to purpuric skin lesion 2015 oct
694 Exanthematous lesion with fever 2016 nov
695 Evaluation of a patient with hyperpigmentation 2017 nov
696 Management of psoriasis 2006 sept
697 Urticaria 2008 oct
698 Discuss psoriasis -diagnosis and management 2008 oct
699 Dermatitis herpetiformis 2010 may
700 Pemphigus vulgaris 2011 may RS
701 Bullous eruptions 2011 nov RS
702 Discuss the clinical diagnosis and management of steven
johnson syndrome and toxic epidermonecrolysis (20)rpeat
nov 2011
2006 april
703 Toxic epidermal necrolyis 2010 oct
704 Erythema nodosum 2015 may
36

37. 705 Causative organisms and treatment of necrotizing fasciitis 2011 nov
706 Molluscum contagiosum 2011 nov RS
707 Dermatological manifestations of bacterial infections 2012 nov rs
708 Sweets syndrome 2013 nov
709 cutaneous manifestation of internal malignancy 2010 oct
710 Describe in detail the dermatological manifestations of
internal malignancies(20)
2014 may
711 Causes and management of diffuse alopecia 2015 may
SYLLABUS
Dissertation
9.1 Every candidate pursuing MD/MS degree course is required to carry out
work on a selected research project under the guidance of a recognised post
graduate teacher. The results of such a work shall be submitted in the form of
a dissertation.
9.2 The dissertation is aimed to train a post graduate student in research
methods and techniques. It includes identification of a problem, formulation of
a hypothesis, search and review of literature, getting acquainted with recent
advances, designing of a research study, collection of data, critical analysis,
comparison of results and drawing conclusions.
9.3 Every candidate shall submit to the Registrar (Academic) of the University
in the prescribed proforma, a synopsis containing particulars of proposed
dissertation work within six months from the date of commencement of the
course on or before the dates notified by the University. The synopsis shall
be sent through the proper channel.
9.4 Such synopsis will be reviewed and the dissertation topic will be
registered by the University. No change in the dissertation topic or guide shall
be made without prior approval of the University.
9.5 The dissertation should be written under the following headings:
i. Introduction
ii. Aims or Objectives of study
iii. Review of Literature
iv Material and Methods
v. Results
vi. Discussion
vii. Conclusion
viii. Summary
ix References
x. Tables
xi. Annexures
37

38. 9.6 The written text of dissertation shall be not less than 50 pages and shall
not exceed 150 pages excluding references, tables, questionnaires and other
annexures. It should be neatly typed in double line spacing on one side of
paper (A4 size, 8.27" x 11.69") and bound properly. Spiral binding should not
be done. A declaration by the candidate that the work was done by him/her
shall be included. The guide, head of the department and head of the
institution shall certify the dissertation.
9.7 Four copies of dissertation along with a soft copy on a CD shall be
submitted to the Registrar (Evaluation), six months before final examination
on or before the dates notified by the University.
9.8 The dissertation shall be valued by examiners appointed by the University.
Approval of dissertation work is an essential precondition for a candidate to
appear in the University examination.
9.9 Guide: The academic qualification and teaching experience required for
recognition by this University as a guide for dissertation work is as per
Medical Council of India Minimum Qualifications for Teachers in Medical
Institutions Regulations, 1998. Teachers in a medical college/institution
having a total of eight years teaching experience out of which at least five
years teaching experience as Lecturer or Assistant Professor gained after
obtaining post graduate degree shall be recognised as post graduate
teachers.
A Co-guide may be included provided the work requires substantial
contribution from a sister department or from another medical institution
recognised for teaching/training by Rajiv Gandhi University of Health
Sciences/Medical Council of India. The co-guide shall be a recognised post
graduate teacher of Rajiv Gandhi University of Health Sciences.
9.10 Change of guide: In the event of a registered guide leaving the college
for any reason or in the event of death of guide, guide may be changed with
prior permission from the university.
10. Schedule of Examination
The examination for M.D / M.S courses shall be held at the end of three
academic years ( six academic terms). The examination for D.M and M.Ch courses
shall be held at the end of three years. The examination for the diploma courses
shall be held at the end of two academic years (four academic terms). The
university shall conduct two examinations in a year at an interval of four to six
months between the two examination. Not more than two examinations shall be
conducted in an academic year.
11. Scheme of Examination
11.1 M.D. / M.S. Degree
38

39. M.D. / M.S. Degree examinations in any subject shall consist of dissertation,
written paper (Theory), Practical/Clinical and Viva voce.
11.1.1 Dissertation: Every candidate shall carryout work and submit a
dissertation as indicated in Sl.NO.9. Acceptance of dissertation shall be a
precondition for the candidate to appear for the final examination.
11.1.2 Written Examination (Theory): A written examination shall consist of
four question papers, each of three hours duration. Each paper shall carry
100 marks. Out of the four papers, the 1st
paper in clinical subjects will be on
applied aspects of basic medical sciences. Recent advances may be asked in
any or all the papers.
11.1.3 Practical / Clinical Examination:
In case of practical examination, it should be aimed at assessing
competence and skills of techniques and procedures as well as testing
students ability to make relevant and valid observations, interpretations and
inference of laboratory or experimental work relating to his/her subject.
In case of clinical examination, it should aim at examining clinical skills
and competence of candidates for undertaking independent work as a
specialist.
The total marks for practical / clinical examination shall be 200.
11.1.4 Viva Voce: Viva Voce Examination shall aim at assessing depth of
knowledge, logical reasoning, confidence and oral communication skills. The
total marks shall be 100 and the distribution of marks shall be as under:
(i) For examination of all components of syllabus 80 Marks
(ii) For Pedagogy 20 Marks
11.1.5 Examiners: There shall be at least four examiners in each subject. Out
of them two shall be external examiners and two shall be internal examiners.
The qualification and teaching experience for appointment as an examiner
shall be as laid down by the Medical Council of India.
11.1.6 Criteria for declaring as pass in University Examination: A candidate
shall secure not less than 50% marks in each head of passing which shall
include (1) Theory, (2) Practical including clinical and viva voce examination.
A candidate securing less than 50% of marks as described above shall
be declared to have failed in the examination. Failed candidate may appear in
any subsequent examination upon payment of fresh fee to the Registrar
(Evaluation).
11.1.7 Declaration of distinction: A successful candidate passing the
University examination in first attempt will be declared to have passed the
examination with distinction, if the grand total aggregate marks is 75 percent
and above. Distinction will not be awarded for candidates passing the
examination in more than one attempt.
Annexure to University Notification No. UA/SYN/ORD/PG-SSC/71/2005-06 dated 28.06.2005)
39

40. Course Description
M.D. – General Medicine
GOAL
The goal of post graduate course in M.D. General Medicine training is to train a MBBS
graduate into a competent, caring and astute Physician who:
Has acquired the competencies pertaining to medicine, that are required to be
practiced in the community, backed by scientific knowledge and skill base. Has acquired
the skills to effectively communicate with the patient, family
and the community.
Is aware of the contemporary advances and developments in medical sciences
related to Medicine and evidences keen interest in continuing medical education.
Is oriented to principles of research methodology.
Recognises the health needs of the population and carries out professional
obligations in keeping with the principles of National Health Policy and professional ethics
and
Be a motivated ‘teacher’ - defined as a doctor keen to share his knowledge
& skills with his medical & paramedical professionals.
OBJECTIVES
The following objectives are laid out to fulfil the goals of the course. These are to be
achieved by the time the candidate completes the course.
At the end of the training period the candidate must be able to :
Practice the speciality of medicine maintaining high professional standards. Identify social,
economic, environmental, biological determinants of an adult and institute diagnostic,
therapeutic, rehabilitative, preventive and promotive measures to provide holistic care.
Collect detailed history, perform full physical examination and make proper clinical
diagnosis. Perform relevant investigative and therapeutic procedures for the care of the
patients and interpret important imaging and laboratory results.
40

41. Diagnose illness based on the analysis of history, physical examination and confirm
on further investigative work up. Plan and deliver comprehensive treatment using the
principles of rational drug therapy.
Manage emergencies efficiently by providing BLS and ALS in emergency situations.
Demonstrate skills in documentation of case details including
epidemiological data.
Knowledge of basic sciences relevant to medicine appropriately. Recognise
conditions that may be outside the area of the speciality / competence and to refer
them to an appropriate specialist.
Respect patients rights and previleges including patients rights to
information and right to seek a second opinion. Demonstrate empathy and humane
approach towards patients and their families and respect their sensibilities.Demonstrate
communication skills in explaining management and prognosis, providing counseling
and giving health education messages to patients families and communities.
Develop skills of a self directed learner, recognise continuing medical
educational needs, use appropriate learning resources, and critically analyse relevant published
literature in order to practice evidence based medicine.
Demonstrate competence in basic concepts of research methodology and
epidemiology.
Facilitate learning of medical / nursing students, practicing physicians,
paramedical health workers and other providers as a teacher – trainer.
Under take audit, use information technology tools and carry out research
– both basic and clinical, with the aim of publishing the work and presenting the work at
various scientific forum.
Professional honesty and integrity are to be maintained.
Be humble and accept the limitation in the knowledge and skill and to seek help from
colleagues when needed.
Duration of the course
The course of the study shall be for 3 years consisting of six terms and each year
consisting of two terms.
41

42. Course content
Knowledge
1. BASIC SCIENCES :
Applied aspects of Anatomy, Physiology, Biochemistry, Pathology, Haematology and
Microbiology and Pharmacology
2. GENERAL MEDICAL TOPICS
History of medicine
Clinical History and examination –Collecting history in detail, carryout clinical
examination of various systems & diagnose the condition on clinical
grounds.
Rational of diagnostic tests – ordering diagnostic tests with prioritising the
needs, based on the clinical, hospital and the socio-economic condition of
the patient.
Concept of Essential Drugs and Rational use of drugs.
Communication skills with patients – Learning effective communication
skills including compassionate explanation and giving emotional support
to the suf fering patient and his family.
Statistics – Descriptive statistics, analytical statistics, qualitative research
methodology, research design and critical review of statistical procedures.
Principles of Evidence based medicine – Understanding journal based literature
study; the value of text book, reference book articles; the value of review
articles; original articles and their assessment. Understanding the value of
retrospective, prospective, randomised controlled and blinded studies – the
principles including meanings of various bio-statistical tests applied in these
studies.
Medical Ethics & Social responsibilities of physicians
Use of computers in medicine
3. GENERAL MEDICINE TOPICS
Genetics: - Basic principles of genetics, molecular basis of genetics, genetic
engineering, human genome mapping, chromosomal disorders, genetic
basis of cancer, genetic & gene therapy.
Immunology: - Basics in immunology, Auto immune disorders, immuno deficiency
diseases, hypersensitivity reactions – anaphylaxis, angioedema, adverse drug
reactions, Complement, HLA system. Transplantation immunology.
Fluid and electrolyte balance / Acid - Base metabolism – The body
42

43. fluid compartments, metabolism of water and electrolytes, factors
maintaining homeostasis, diagnosis and management of acidosis and alkalosis &
Electrolyte imbalance.
Blood transfusion: – Blood grouping, cross matching, component therapy,
complications of blood transfusion, blood substitutes.
Shock and Multi-organ Failure:- Types of shock, diagnosis, resuscitation
pharmacological support, ARDS, ventilator support and its prevention.
Nutrition : – RDA of nutritional substances, nutritional assessment, nutritional recall,
metabolic response to stress, malnutrition, PCM, nutritional deficiency states,
nutritional response in stress, enteral and parenteral nutrition, dietary advice in
obesity, DM, renal, hepatic failure, hyperlipidaemia, IHD.
Poisoning: - OP compound, sedatives, alcohol, corrosives, anti-convulsants, general
principles of management & specific management of poisons including snakes
bites, scorpion stings.
Toxicology – Heavy metal posoning, Flurosis, Lathyrism
Pre anaesthetic and post operative medical problems
Geriatric Medicine
Pregnancy Medicine
Adolescent Medicine
4. INFECTIOUS DISEASES
Basic considerations: - Host- parasite interactions, Immunisation principles,
Lab.diagnosis of infectious diseases, Vaccination (BCG, Typhoid, Tetanus, Hepatitis A &
B), Antimicrobial agents, Mol. Mechanism of microbial pathogenesis. Clinical
Syndromes (Community setting): - Septic shock, Infective endocarditis, PUO, Infectious
diarrhoea, Bacterial Food Poisoning, Common STD Syndromes, Inf. Complications
of Bites and stings, Infections of skin, muscle and soft tissue, Osteomyelitis,
Intra-abdominal infections and abscess, P.I.D. Nosocomial Infections: Hospital
Acquired infections, Infections in Transplant pts, Infection control in hospital.
Bacterial Infections: Pneumococcal, Staphylococcal, Streptococcal & Enterococcal,
Tetanus, Diphtheria, Anthrax, Listeria, Gas gangrene, Botulism, Other clostridial
infections.
Meningococcal, H.pylori, Salmonella, Shigella, Cholera, Legionella, Moraxella
Brucella, Pseudomonas, Mixed anaerobic infections, H. influenza, Gonococcal,
Pertussis, Plague, Campylobacter, Donovanosis, Actinomycosis.
Anaerobic infections
Microbacterial diseases: Tuberculosis, Leprosy, Non-tubercular mycobacterium.
Spirochaetal: Syphilis, Leptospirosis, Endemic trepanomatosis.
Rickettsiae: R.M. Spotted fevers
Mycoplasma: M. pneumoniae
Chlamydia: Psittacosis
Fungal I nfections: Candidiasis, P.carinii, Aspergillosis, Mucor mycosis,
Coccidiodomycosis, Cryptococcosis, Histoplasmosis.
Viral Infections: Antiviral chemotherapy
DNA viruses: Herpes simplex, CMV, Chicken pox vaccinia, other pox viruses.
Varicella zoster, Parvovirus
43

44. Ebstein Barr, HPV
DNA & RNA respiratory viruses: Influenza
RNA Viruses: Rabies, ARBO viruses (dengue, KFD, Japanese encephalitis), Human retrovirus,
Entero, Mumps, Rubella
HIV & AIDS: - Epidemiology, clinical stages, complications, opportunistic
infections(OI), laboratory investigations, HAAR T, PEP & counselling.
Protozoal and Helminthic infections : Life History, Clinical Manifestations, lab.
diagnosis and therapy, Amoebiasis, Malaria, Giardiasis, Taeniasis, Echinococcosis,
E.vermicularis, T. trichiura, Ascariasis, Hookworm infections, Filariasis, Leishmaniasis, Other
free living amoeba, Toxoplasmosis, Trichinella, Trypanosomiasis, Trichomoniasis, H.nana,
D.latum, Schistosomiasis, Larva migrans syndrome.
5. CARDIO VASCULAR DISEASES:
Rheumatic Fever & heart diseases Congenital
heart diseases
Atherosclerosis, coronary artery disease
Primary and Secondary hypertension
Cardiac failure
Cardiac arrhythmias – tachy & brady arrhythmias, heart blocks
Infective endocarditis
Myocardial & Pericardial diseases
Pregnancy and heart diseases
Diseases of aorta
DVT and pulmonary embolism
Peripheral arterial and venous diseases
Acute and Chronic cor pulmonale
Disease of Lumphatic system
Noncardiac surgery in cardiac patients - assessment for anaesthesia and surgery
Cardiac drugs and drug interaction
Guidelines published by standard cardiology journals.
Apart from pathophysiology, clinical features and management, the importance of
primary and secondary prevention must be stressed.
Clinical cardiology.
* Adequate exposure to cardiac OPD work, cardiology ward work and coronary care
unit:
* One month in cardiac OPD / ward, and one month in CCU
* During the posting, the student should accompany his cases for stress-ECG
(TMT ), echocardiography and cath lab.
6. RESPIRATORY MEDICINE
Applied aspects of Respiratory system & Respiratory Physiology.
Mycobacteriology: Diagnostic methods, pathogenesis of Mycobacterial diseases,
their clinical manifestations. Pulmonary and extra pulmonary, as well as
44

45. disseminated tuberculosis, its pathogenesis, clinical features, diagnosis and
management, National programme on Tuberculosis including DOTS.
Non tuberculous Respiratory infection:
Community and hospital acquired pneumonias, infections of tracheo- bronchial tree
including cystic fibrosis, parasitic and fungal diseases of lungs, HIV infections and lungs.
Allergic diseases of respiratory system including bronchial asthma.
Interstitial, industrial, occupational lung diseases including Interstitial Pulmonary Fibrosis.
Suppurative lung diseases
Granulomatous diseases of lungs including sarcoidosis.
Pulmonary manifestations of systemic diseases and drug induced lung diseases.
Tropical pulmonary eosinphilia
Diseases of pluera, mediastinum and diaphragm.
Intra-thoracic malignancies including etiology, diagnosis, staging and management of lung
cancer.
Sarcoidosis
7. CENTRAL NERVOUS SYSTEM
Applied aspects of anatomy -Brain and Spinal cord
Evaluation of CNS diseases
Clinical approach to: - Coma, Headache, Seizure, Dementia, Aphasia,
Sleep disorders
Brain death
Cerebrovascular diseases
Cranial Nerve disorders
CNS infections, Bacterial, Viral, Fungal, Neurotuberculosis, parasitic.
Motor system diseases
Tumors of Brain and Spinal cord
Extra pyramidal disorders Cerebellar
disorders Demyelinating diseases
Neuro-degenerative disorders Nutritional
disorders affecting nervoussystem, Cerebrovascular
anomalies
Peripheral Neurites, polynurites & Guillain Barre Syndrome
Cervical Spondylosis
Disorders of muscle-Dystrophy, Myopathies & Myasthenic syndrome
8. GASTRO INTESTINAL & HEPATOBILIARY SYSTEM
Disease of Oesphagus
Peptic ulcer disease and its management
Upper Gastrointestinal bleed
45

46. Lower Gastrointestinal bleed
Approach to Mal-absorption and Mal-digestion
Inflammatory bowel diseases
Irritable Bowel Syndrome (I.B.S.), Gastrointestinal motility disorders
Chronic Diarrhoea Disorders
of Peritoneum G.I function
tests
Liver
Bilirubin metabolism
Cirrhosis of Liver, Biliary Cirrhosis & N.C.P.F& Budd Chiari syndrome
Acute & Chronic Hepatitis - Viral, Toxic
Alcoholic Liver Disease
Amoebic Liver Abscess
Obstructive Jaundice
Acute & Chronic Hepatic insufficiency
Cong. Hyperbilirubinemias
Tumours of the liver
Drugs and Liver
Diseases of Gall bladder
AC & Chronic cholecystitis
Gall Stone
Diseases and disorders of Pancreas :- Acute & Chronic Pancreatitis
9. ENDOCRINOLOGY & METABOLISM
Principles of Endocrinology : Mechanism of action of hormones & receptors
Assessment of endocrine function
Hypothalamus & Pituitary : Approach to pituitary disease, diseases of anterior
& posterior-pituitary tumors, Acr omegaly, short statur e, pr olactinoma,
diabetes insipidus, SIADH, Cushing’s disease, Panhypopituitarism,
Sheehan’s syndr ome, Non secr etary adenoma.
Pancr eas : Hypoglycemia, Insulinomia
Diabetes Mellitus : Prevalence, Etiopathogenesis, ADA criteria for diagnosis,
ADA classification, Clinical features, investigations, Complications-micro
& macro-vascular, Management-Diet, Exercise, oral hypoglycemics, Insulin
therapy in Type 1 & type 2, Gestational diabetes, Diabetic keto-acidosis,
HONK, Hypoglycemia
Thyroid : Iodine metabolism, Iodine deficiency disorder, Synthesis and secretion of
thyroid hormone, hypothyroidism, hyperthyroidism, Cretinism, Sick euthyroid
syndrome, thyroiditis, evaluations of nodule, ca. thyroid.
Parathyroid : Primary hyperparathyr oidism, Hypoparathyr oidism, Tetany,
Pseudohypoparathyroidism.
46

47. Adr enal :– Ster oid biochemistry, Addison’s disease, Cushing’s syndr ome,
Congenital adrenal hyperplasia, Pheochromocytoma, primary aldosteronism.
Gonads: – testes – Men- Hypogonadism – PGAS, hypogonadotropic (Kallman’s
syndrome), Hypergonadotropic (Klinefelter’s syndrome), delayed puberty,
precocious puberty, infertility.
Ovary : Delayed puberty – Turner’s syndrome, polycystic ovarian disease, Hirsuitism,
precocious puberty, approach to amenorrhea, postmenopausal syndrome, current
concepts in management
10. SEXUAL MEDICINE:
Applied aspects of anatomy and physiology of Reproductive system – male & female.
Human sexual response.
Etiology, Clinical features and management of common sexual problems – male & female.
Effects of psychiatric illness and systemic diseases including commonly used drugs on
reproductive system.
Infertility – male & female – etiology, clinical features, investigations and Physician’s
role in management.
11. METABOLIC BONE DISORDERS (MBD)
Bone mineral, metabolism, osteoporosis
-Osteomalacia & rickets
Carcinoid tumours, hyperlipidemia.
12. NEPHROLOGY
Evaluation of patient with renal diseases
Interpretation of laboratory tests
Acute renal failure
Chronic renal failure
pathogenesis, pathology, clinical features
conservative management
Diet in renal failure
Acute glomerulonephritis including idiopathic GN
Nephrotic syndrome
Urinary tract infection
Drugs and kidney
Nephrolithiasis and obstructive disorder
Renal involvement in systemic diseases
Diabetic nephropathy
Pregnancy and kidney
Basics of renal transplantation
Organ donation
Concept of brain death and cadaveric transplantation
Electrolyte disturbance and its management
Immuno- suppressive drugs
Slow continuos renal replacement therapy
47

48. 13. HAEMATOLOGY:
Haemotopoiesis
Anaemias- causes, clinical features and laboratory approach and treatment. Iron
deficiency, megaloblastic, haemolytic and aplastic anaemias.
Various thalasemic syndromes, Hb Electrophoresis.
Polycythaemias.
Problem of Iron over load
Autoimmune blood disorders
Transfusion medicine
Recognition and management of Transfusion disorders
Transfusion in patients with Hematological diseases (component therapy)
Coagulopathy
Hypercoagulable state
Leukaemias and its managements
Myelodysplastic syndromes and Mycloproliferative disorders
Platelet disorders-Purpuras - Primary & sec.
Therapeutic plasmapharesis and Cytapharesis. ABVP,
CHOPChemotherapy.
14. RHEUMATOLOGY AND CONNECTIVE TISSUE DISORDERS
Structure of connective tissue – collegen, elastin & proteoglycans
Immunological mechanisms & Immunogen in
Rheumatoid arthritis
SLE
Osteo arthritis
Vasculitis
Sero negative spondyloarthropathy
Crystal arthritis
Inflammatory /metabolic myopathies
Arthropathies associated with Endocrine
diseases
Haematologic diseases
Malignant diseases
Fibromyalgic syndromes
Low back pain
Systemic selerosis
Myositis
Mixed connective Tissue disorder (MCID)
15. EMERGENCY MEDICINE
Basic & Advanced Life Support
Shock Syndromes
Anaphylaxis
Acid base imbalance
48

49. Multi organ failure
Poisoning – OP compound, sedatives
Basics of mechanical ventilation
Transfusion reaction
Upper G.I hemorrhage Upper
airway obstruction Tension
Pneumothorax Acute asthma,
ARDS Cardiac arrest
Cardiac Temponade
Hypertensive emergencies & urgencies
Status epilepticus
Coma in Diabetes Endocrinal
emergencies Cerebral
Malaria Emergencies in
cancer Infections in ICU
Antibiotic usage in ICU
Enteral & Parental Nutrition
Brain death
List of Skills
Cardiopulmonary resuscitation / cardio-version / defibrillation
Emergent airway intubation
Central venous cannulation
Arterial cannulation
Mechanical ventilation
Temporary transvenous pacemaker
Percutaneous tracheostomy
Pericardiocentesis
Therapeutic bronchoscopy, Tube thoracotomy
16. MEDICAL ONCOLOGY
Basics of Oncology
Normal cell, Cancer cell- Cell cycle & its Regulation
Molecular Biology Techniques such as Southern blot, Northern blot, Western blot,
Karyotyping , FISH, PCR.
Metastatic cascade
Angiogenesis
Basic principles of Chemotherapy-
Drug classification
Drug action Side
ffects
Radiotherapy
Structure of Atom, radioactivity and its effect on cell, side ef fects
Clinical oncology
Hematologic Cancers
Hematopoiesis
Leukemias & Lymphomas – Classification, Diagnosis, management
Solid tumors - Br.Carcinoma, Hepatomas, MM- Principles of Management
Blood component therapy
Bone Marrow transplant
Newer Modalities in Therapy & Supportive Care
Biologic Response Modifiers
49

50. Gene therapy
Stem cell transplant
Newer antibiotics
Nutritional support
Growth factors
17. RADIO DIAGNOSIS
I General:-The importance and scope of different radiological examinations in the
diagnosis, treatment and management of various diseases.
II. Newer imaging modalities: Different imaging modalities including the newer
imaging techniques - ultrasonography, colour doppler imaging, colour flow
mapping, Computed Tomography, MRI, Nuclear imaging, PET and SPECT- basic
principles
III. Protocols to be followed while referring for various routine investigations
Barium studies
Ultrasonography
Computed tomography
MRI imaging
Nuclear medicine investigations
IV. Various contrast investigations and contrast materials used in imaging techniques
and adverse reactions.
V. Interpretation of plain, contrast X-rays, Ultrasonography, CT,MRI & NM
50

51. 18. PSYCHIATRY
Objectives
Students are required to identify and understand:
Delirium and dementia - Common causes
- Principles of management of each
syndrome
Misuse of and dependence on - Diverse presentations
alcohol and drugs - Complications
- Outcomes of the conditions
- Principles of prevention and treatment
Schizophrenia and related - Recognition of disorders disorders
(including acute and - Treatment of an acute episode
chronic delusional disorders)- - Principles of long term management
Depressive and manic disorders - Recognition of mania and depressive
sorders of all degrees of severity - Co-morbidity of depressive and other
disorders
- Treatment of uncompleted cases
Acute reactions to stress, PTSD, - Recognition of these conditions
and adjustment disorders - Management of uncompleted cases
(including reactions to terminal
illness and normal and abnormal
grief)
Anxiety, phobic and obsessional - Recognition of disorders
disorders - Treatment of uncomplicated anxiety and
obsessional disorders
Somatoform disorders - How physical symptoms arise without
physical pathology
- Concepts of conversion disorders
- Hypochondriasis
- Somatoform disorders
- Principles of management

52. Disorders of eating sleeping, - Clinical presentations psychosexual
functions - Principles of management of
uncomplicated cases
Personality disorders - Concepts of personality and personality
disorders
- Influence on physical and mental
illnesses
Mental retardation - Principles of prevention
- Recognition of the most common
syndromes
- Principles of management
Childhood psychiatric disorders - Common psychiatric disorders of
childhood and adolescence
- Principles of management
Old age psychiatric disorders - Impact of aging on health and psychiatric
illness
- Recognition and principles of management of
psychiatric disorders in the elderly
Suicide - Assessment of risk
- Management of potentially suicidal patients
and of those recovering from self – harm
Other syndromes - Dangerousness and the management of
potentially violent people
- Physical abuse of children and adults

53. 19. DERMATOLOGY / STD
The skin manifestations of various diseases:-
Leprosy
STD
HIV
Systemic infections and infestations
Internal malignancy
Drug reactions
Systemic diseases with skin manifestation
Psoriasis
Vitiligo
Fungal infections
Lichen planus
Viral , bacterial infections
Cutaneous metastasis
Panniculitis
20. OCCUPATIONAL DISEASES
Note : The list of topics given are general guidelines. They are neither comprehensive nor all
inclusive.

54. SKILLS TO BE ACQUIRED
List of essential competencies.
Clinical Assessment skills.
Laboratory diagnostic abilities.
Interpretation abilities.
Communication Abilities, and
Therapeutic skills.
Skill of history taking
Active and positive listening .
Empathy.
Non-verbal communication.
Art of history taking in handicapped individuals like deaf , elderly, aphasics.
Ascertaining life history and life style.
Tactful elicitation of personal and confidential History.
Carry out meticulous general & systemic examination. Specific
areas of examination based on clues in the history. Make a
personality assessment.
Information, evaluation skills, (interpretation).
Diagnostic formulation and differential diagnosis.
Evaluate, role of personal and social factors contributing to the patient’s
behavior pattern.
For mulate plan of management which includes r eferral to a specialist,
whenever appropriate.
Information-giving skills.
Pass infor mation to pr omote health.
Explain the implication of diagnosis to patient as well as the family. Inform
the patient about beneficial aspects and also potential adverse effects of
treatment.
Philosophical approach to life and death.
Reporting skills.
Report verbally or in writing or any other media of communication
To medical colleagues. To
lay people.
To Non-medical agencies involved in patient car e.
Promote public education.
Promote skills in case reporting and publication of data.
Treatment skills.
Promote compliance with prescribed treatment.
Basic prescribing skills for medical disorders commonly encountered

55. (rational drug prescribing skills.)
Recognise earliest adverse effects of treatment and distinguish them from
those of symptoms of illness.
Learning skills.
Sustained self directed independent learning. Keeping
abr east with advances in medical practice. Internalising
the concept of life long learning.
Access to computer usage, including internet browsing.
Critical appraisal of latest and best information and data analysis.
Skills of using library facilities (including electronic media).
Team work skills
Co-operate with: Medical colleagues, Non medical health care workers, Patient
and his family organizations, Community services.
Non Governmental Organisations & General Public. List of clinical, procedural and
practical skills
Competency list
Note: Figures shown against the items indicate minimum number.
Key PI = Performs independently, PA = Performs under assistance
Description of competencies Number
Clinical Assessment Skills (All PI)
Elicit a detailed clinical history including
- Dietary recall, calorie and protein estimation 50
Perform a thorough physical examination including
Anthropometry 10
Optic fundi examination 2 0
Per rectal examination 0 5
Procedural skills (All PI)
Test dose 05
Sampling for fluid cultures 10
IV- Infusions 20
Intravenous cannulation 10
Venesection 05
ECG recording 50
Pleural tap 10
Peritoneal tap 10
Pericardio-centesis 05
Lumbar puncture 15
Resuscitation
BLS 30

56. Description of competencies Number
ALS 10
Central line, CVP - 05
Blood and blood component (platelet, FFP, etc.,) transfusions 10
Arterial puncture for ABG 20
Liver biopsy 10
Liver abscess aspiration 05
Bone marrow aspiration and biopsy 10
Peritoneal /Pleural 2 each
Glucometer usage 30
Urine analysis 20
Urinary Catheterization 15
R yle’s , Stomach tube use 20
Sputum- Gram’s / AFB staining 10 each
Respiratory management (All PI)
Nebulization 30
Inhaler therapy 30
Oxygen delivery 30
List of PA skills:
Peritoneal dialysis 05
Haemodialysis 05
Critically ill person (All PI skills)
Monitoring a sick person 50
Endotracheal intubations 20
CPR 10
Using a defibrillator 10
Pulse oximetry 50
Feeding tube use 10
Intercostal tube placement with underwater seal 10
Sedation 10
Analgesia 20
Venesection
CUP monitoring
List of PA skills:
Assessment of brain death 10
Laboratory – Diagnostic Abilities (All PI) Urine protein, sugar, microscopy 10
Peripheral blood smear 10

57. Description of competencies Number
Malarial smear 10
Ziehl Neelsen method smear – sputum, gastric aspirate 10
Gram’s stain smear – CSF, pus 10
Stool pH, occult blood, microscopy 10
KOH smear 2
Cell count –CSF, pleural, peritoneal, any serous fluid 20
Interpretation Skills (All PI)
Clinical data (history and examination findings), formulating a differential diagnosis in
order of priority, using principles of clinical decision – making, plan investigative work-
up, keeping in mind the cost – effective approach i.e., problem solving and clinical
decision making.
Blood, urine, CSF and fluid investigations – hematology, biochemistry. X-
ray chest, abdomen, bone and joints
ECG
Treadmill testing
ABG analysis
CT scan chest and abdomen CT
scan head and spine Barium
studies
IVP, VUR studies Ultrasound
abdomen Pulmonary function
tests
Immunological investigations
Echocardiographic studies
Interpretation under supervision (PA)
Description of competencies Number
Hemodynamic monitoring 1 0
Handling Ventilators 1 0
Cardiac pacing 0 5
GI Endoscopy – Upper 2 0
Lower 0 5
Bronchoscopy 0 5
Tracheostomy 0 5
U /S abdomen 2 0
U / S guided aspiration 1 0
ECHO 2 0
TMT 2 0
Nuclear isotope scanning 1 0
MRI scanning of head / chest 1 0

58. To be familiar with
Radio frequency ablation
PTCA & Stent
Peripheral & Carotid doppler
Peripheral Angioplasty
PFT
Nerve Conduction Studies
Interpretation Skills
All Haematological & Biochemical investigations
X-ray of chest, abdomen, bones & joints
Barium studies
ECG Echo
TMT
Ultra-sound abdoman
Doppler Studies
CT / MRI of head, chest & abdoman
Immunological studies & Polymerase chain reaction
PFT
EEG / ENMG
Nutritional advice in DM
Obesity / Malnutrition
Cirrhosis of liver
Renal failure
Hypertension / Ischemic Heart Disease
Diarrhoea
Principles of Rehabilitation in
Strokes & Neuro degenerative diseases
Muscular dystrophies
COPD / Suppurative lung diseases
IHD
Epilepsy & Others
Demonstrating professionalism ethical behaviour (humane and professional care
patients ) , Self directed learning
Utilization of information technology, Medline search, Internet access, computer
usage, identifying key information sources, literature search, information
management
Research methodology -interpretation and presentation of scientific data
Therapeutic decision-making
Managing multiple problems simultaneously
Assessing risks, benefits and costs of treatment options
Involving patients in decision-making
Selecting specific drugs with in classes
Rational use of drugs

59. Training Programme:
To attain proficiency in the subject and to practice the post-graduate student has to be trained
in an organised and structured manner. Graded responsibility is to begiven to the post-
graduate student on a progressive scale in an integrated manner in the three year course with the
trainee being able to attain his
/ her identity as a physician capable of holistic approach to the patient care. Independent self
- directed problem based learning.
Skill acquisition oriented learning. Ambulatory
and Emergency care.
I year
 Ability to obtain a clear and thorough history, physical examination and follow up notes.
Capability to manage routine & on call duties of the wards. Supervising and follow up of
investigations. Ability to develop a rational treatment plan. Initiate and carry out treatment.
Identify emergency problems, seek help from seniors & initiate treatment so as to develop
decision making and judgment skills.
 Supervise house- surgeon’s work.
 To prepare synopsis for dissertation.
II year
 Develop basic knowledge of the speciality subject in the care of the patient.
 Witness / perform procedures in the specialty.
 Learn the indications and contraindications of the procedures.
 To learn when to refer a case to the sub-specialist.
 To know when to intervene and when not to intervene in a case.
 To carry out data collection for the dissertation.
III year
 Able to handle case independently- diagnose and manage the cases in the unit/ ward.
 Diagnose and treat cases in emergency & ICU set up.
 Problem identification of referral cases & advice suitably. Supervise I yr post-graduate students
 Teach interns
 Teach undergraduates
 Help junior residents in his responsibilities at all levels and to intervene at appropriate
time when the occasions demand
 In problem cases, to seek help from senior staff members.
 Successfully complete data collection, analysis and writing up & submission of
dissertation.

60. ROTATION POSTINGS
General Guidelines
(a) Where all departments of sub-specialties are available:
Department Duration of posting Year of posting
General Medicine 24 months I/III YR Emergency
2months II
I.C.U. 1 month II Cardiology
Including ICCU 2 months II Neurology 1
month II Gastroenterology
1 month II Respiratory
Diseases 1 month II Nephrology 1
month II Endocrinology 15
days II Skin 15 days
II Psychiatry 15
days II YEAR
(b) Where separate sub-specialties are NOT available:
Minimum 4 months in Emergency and 1 month in ICU. If any sub-specialty is available,
the duration of posting in the department shall be as in item 1. The rest of the training will be in
the department of Medicine but the specialist shall ensure:
i) Adequate exposure to cases of sub-specialties.
ii) A minimum exposure to the following procedures:
Department No. of Procedures
Cardiology 5
Gastroenterology 5
Respiratory Medicine 1 0
Neurology 1 0
Nephrology-Haemo dialysis and
Peritonial dialysis 5 each
TMT 5
Holter 5
Upper GI Endoscopy 1 0
Colonoscopy 3
Sigmoidoscopy 3
Bronchoscopy 2
Pleural biopsy 2
EMG 2
EEG 5
Muscle biopsy 2
Peritoneal dialysis 5
Haemo dialysis 5
iii) In addition, a minimum number of cases of the following sub- specialities must be seen and
entered in the log book: